Bart van Hoek
Professor emeritus Gastroenterology and Hepatology, in particular hepatology
- Name
- Prof.dr. B. van Hoek
- Telephone
- 071 5269111
- b.van_hoek@lumc.nl
- ORCID iD
- 0000-0001-6527-764X
Bart van Hoek, M.D., Ph.D. is Gastroenterologist –Hepatologist and Professor of Hepatology at Leiden University and Leiden University Medical Center, Leiden, The Netherlands. He is Medical Director of the Liver Transplant program -which he co-founded-and of the Hepatology Unit of the Dept. of Gastroenterology and Hepatology. Currently he chairs the joint meetings of the three Dutch liver transplant centers and is the representative for the Netherlands in the European Liver and Intestinal Advisory Committee (ELIAC) of Eurotransplant.
More information about Bart van Hoek
Hepatology
The chair on Gastroenterology and Hepatology, especially Hepatology especially concerns Liver Disease and Liver Transplantation.
Current lines of research are auto-immune liver diseases (auto-immune hepatitis, PSC, PBC and overlap syndromes), alpha-1-antitrypsin deficiency, liver failure, complications of cirrhosis, fibrogenesis and fibrosis and influence of stem cells, and all aspects of liver transplantation -with an accent on immunosuppression, infections, ischemia-reperfusion injury and bileduct complications. Research includes extrahepatic manifestations of liver disease (NWA).
Academic career
- 1983 – 1988 Specialization in Internal Medicine, UMC Groningen, Groningen, The Netherlands
- 1988-1989 Internist, Dept. of Hepatology, UMC Groningen, Groningen, the Netherlands
- 1989 PhD-Thesis University of Groningen on ‘Clinical, immunological and pathological monitoring of auto-immune chronic active hepatitis’
- 1989-1991 Fellowships in Surgery Research and Hepatology, Mayo Clinic, Rochester, MN, U.S.A.
- 1991-1992 Internist/Hepatologist, training as Gastroenterologist, Maastricht UMC Maastricht, Maastricht, Netherlands
- 1993-now Consultant Gastroenterologist & Hepatologist and Internist, Medical Director of Liver Transplantation and Hepatology, Dept of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands
- 2009 - now Professor of Hepatology, Leiden University, Leiden, The Netherlands
- 2010 April 26 oration: ‘Within and around the liver’
Professor emeritus Gastroenterology and Hepatology, in particular hepatology
- Faculteit Geneeskunde
- Divisie 2
- Maag-, Darm- en Leverziekten
- Duijzer, R.; Bernts, L.H.P.; Geerts, A.; Hoek, B. van; Coenraad, M.J.; Rovers, C.; Alvaro, D.; Kuijper, E.J.; Nevens, F.; Halbritter, J.; Colmenero, J.; Kupcinskas, J.; Salih, M.; Hogan, M.C.; Ronot, M.; Vilgrain, V.; Hanemaaijer, N.M.; Kamath, P.S.; Strnad, P.; Taubert, R.; Gansevoort, R.; Torra, R.; Nadalin, S.; Suwabe, T.; Gevers, T.J.G.; Cardinale, V.; Drenth, J.P.H. & Lantinga, M.A. (2024), Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework, The Lancet Gastroenterology & Hepatology 9(9): 884-894.
- Pongracz, T.; Biewenga, M.; Stoelinga, A.E.C.; Bladergroen, M.R.; Nicolardi, S.; Trouw, L.A.; Wuhrer, M.; Haan, N. de & Hoek, B. van (2024), Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases, Journal of Translational Medicine 22(1).
- Stoelinga, A.E.C.; Biewenga, M.; Drenth, J.P.H.; Verhelst, X.; Meer, A.J.P. van der; Boer, Y.S. de; Bouma, G.; Vries, E.S. de; Verdonk, R.C.; Berg, A.P. van der; Brouwer, J.T.; Vanwolleghem, T.; Lammers, W.; Beuers, U.; Sarasqueta, A.F.; Verheij, J.; Roskams, T.; Crobach, S.; Tushuizen, M.E.; Hoek, B. van & Dutch Autoimmune Hepatitis Study (2024), Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy, JHEP Reports 6(7).
- Colapietro, F.; Maisonneuve, P.; Lytvyak, E.; Beuers, U.; Verdonk, R.C.; Meer, A.J. van der; Hoek, B. van; Kuiken, S.D.; Brouwer, J.T.; Muratori, P.; Aghemo, A.; Carella, F.; Berg, A.P. van den; Zachou, K.; Dalekos, G.N.; Zeo-Sanchez, D.E. di; Robles, M.; Andrade, R.J.; Montano-Loza, A.J.; Brand, F.F. van den; Slooter, C.D.; Macedo, G.; Liberal, R.; Boer, Y.S. de; Lleo, A.; Dutch AIH Study Grp & Int Autoimmune Hepatitis Grp (2024), Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis, Journal of Hepatology 80(1).
- Snijders, R.J.A.L.M.; Stoelinga, A.E.C.; Gevers, T.J.G.; Pape, S.; Biewenga, M.; Tushuizen, M.E.; Verdonk, R.C.; Jonge, H.J.M. de; Vrolijk, J.M.; Bakker, S.F.; Vanwolleghem, T.; Boer, Y.S. de; Pronk, M.A.M.C.B.; Beuers, U.; Meer, A.J. van der; Gerven, N.M.F. van; Sijtsma, M.G.M.; Eijck, B.C. van; Ijzendoorn, M.C. van; Herwaarden, M. van; Brand, F.F. van den; Korkmaz, K.S.; Berg, A.P. van den; Guichelaar, M.M.J.; Levens, A.D.; Hoek, B.V. van; Drenth, J.P.H. & Dutch Autoimmune Hepatitis (2024), An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis, Journal of Hepatology 80(4).
- Ruijter, B.N.; Muiselaar, R.F.J.; Tushuizen, M.E. & Hoek, B. van (2024), Bacterial infections after liver transplantation and the role of oral selective digestive decontamination, Transplantation Proceedings 56(2): 427-433.
- Snijders, R.J.A.L.M.; Stoelinga, A.E.C.; Hoek, B. van & Drenth, J.P.H. (2024), Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis", Journal of Hepatology 81(1): e43-e44.
- Meinderts, J.R.; Metselaar, H.J.; Hoek, B. van; Hoed, C.M. den; Rijntjes, D.; Groenewout, M.; Vilsteren, F.G.I. van; Groen, H.; Berger, S.P.; Prins, J.R. & Jong, M.F.C. de (2024), Long-term maternal outcomes of pregnancy after orthotopic liver transplantation in the Netherlands, Liver Transplantation.
- Veer, R.C. de; Hooff, M.C.B. van; Werner, E.; Beuers, U.; Drenth, J.P.H.; Cuperus, F.J.C.; Hoek, B. van; Veldt, B.J.; Klemt-Kropp, M.; Meer, S. van; Verdonk, R.C.; Flink, H.J.; Vrolijk, J.M.; Gevers, T.J.G.; Ponsioen, C.Y.; Borg, M.J. ter; Soufidi, K.; Boersma, F.; Jonge, H.J.M. de; Wolfhagen, F.H.J.; Baak, L.C.; Onderwater, S.L.; Bergeijk, J.D. van; Putten, P.G.; Bruin, G.J.D.; Adang, R.P.R.; Boer, W. de; Borg, F. ter; Soest, H. van; Janssen, H.L.A.; Hansen, B.E.; Erler, N.S.; Meer, A.J. & Meer, A.J. van der (2024), Incidence and prevalence of primary biliary cholangitis in the Netherlands, JHEP Reports 6(8).
- Gatselis, N.K.; Zachou, K.; Loza, A.J.M.; Cançado, E.L.R.; Arinaga-Hino, T.; Muratori, P.; Efe, C.; Floreani, A.; Invernizzi, P.; Takahashi, A.; Takaki, A.; Beretta-Piccoli, B.T.; Hoek, B. van; Lytvyak, E.; Guedes, L.V.; Purnak, T.; Cazzagon, N.; Lygoura, V.; Arvaniti, P.; Rigopoulou, E.I.; Muratori, L.; Dalekos, G.N. & Int Autoimmune Hepatitis Grp (2023), Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH), European Journal of Internal Medicine 116: 43-50.
- Ruijter, B.; Tushuizen, M.; Moes, D.J.; Klerk, B. de & Hoek, B. van (2023), Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: the randomized controlled FK04 trial, Transplantation 107(9): 215-215.
- Goudsmit, B.; Prosepe, I.; Tushuizen, M.E.; Mazzaferro, V.; Alwayn, I.P.J.; Hoek, B.V.; Braat, A.E. & Putter, H. (2023), Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma, JHEP Reports 5(12).
- Beukel, M.D. van den; Stoelinga, A.E.C.; Meer, A.J. van der; Meulen, S. van der; Zhang, L.; Tushuizen, M.E.; Hoek, B. van & Trouw, L.A. (2023), Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment, Frontiers in Medicine 10.
- Snijders, R.; Stoelinga, A.; Gevers, T.; Pape, S.; Biewenga, M.; Tushuizen, M.; Verdonk, R.; Jonge, H.M. de; Vrolijk, J.M.; Bakker, S.; Vanwolleghem, T.; Boer, Y. de; Baven-Pronk, M.; Beuers, U.; Meer, A. van der; Gerven, N. van; Sijtsma, M.; Verwer, B.; IJzendoorn, M. van; Herwaarden, M. van; Brand, F. van den; Korkmaz, K.S.; Berg, A. van den; Guichelaar, M.; Levens, A.; Hoek, B. van & Drenth, J.P.H. (2023), Mycophenolate mofetil is superior to azathioprine for the induction of remission in treatment-naive autoimmune hepatitis [CAMARO trial], Journal of Hepatology 78: S15-S15.
- Beukel, M.D. van den; Stoelinga, A.E.C.; Meer, A.J. van der; Meulen, S. van der; Zhang, L.; Tushuizen, M.E.; Hoek, B. van & Trouw, L.A. (2023), Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment, Frontiers in Medicine 10.
- Bot, D.; Lucassen, C.; Werkman, M.; Dijk, S. van; Feshtali, S.S.; Tushuizen, M.E. & Hoek, B. van (2023), Skeletal muscle mass in patients with end-stage liver disease, Clinical Nutrition ESPEN 55: 407-413.
- Stevens, L.J.; Dubbeld, J.; Doppenberg, J.B.; Hoek, B. van; Menke, A.L.; Donkers, J.M.; Alsharaa, A.; Vries, A. de; Vaes, W.H.J.; Knibbe, C.A.J.; Steeg, E. van de & Alwayn, I.P.J. (2023), Novel explanted human liver model to assess hepatic extraction, biliary excretion, and transporter function, Clinical Pharmacology & Therapeutics 114(1): 137-147.
- Mulder, M.B.; Hoek, B. van; Berg, A.P. van den; Polak, W.G.; Alwayn, I.P.J.; Jong, K.P. de; Winter, B.C.M. de; Verhey-Hart, E.; Erler, N.S.; Hoed, C.M. den & Metselaar, H.J. (2023), Three-year results of renal function in liver transplant recipients on low-dose sirolimus and tacrolimus, Liver Transplantation 29(2): 184-195.
- Mulder, M.B.; Busschbach, J. van; Hoek, B. van; Berg, A.P. van den; Polak, W.G.; Alwayn, I.P.J.; Winter, B.D.M. de; Verhey-Hart, E.; Erler, N.S.; Hoed, C.M. den & Metselaar, H.J. (2023), Health-related quality of life and fatigue in liver transplant recipients receiving tacrolimus versus sirolimus-based immunosuppression, Transplantation 107(12): 2545-2553.
- Kamp, J.C.; Kappe, N.N.; Moro, C.F.; Fuge, J.; Kuehnel, M.P.; Wrenger, S.; Welte, T.; Hoek, B. van; Jonigk, D.D.; Khedoe, P.P.S.J.; Strnad, P.; Björnstedt, M.; Stolk, J.; Janciauskiene, S. & Nemeth, A. (2023), Fibrosis-related gene profiling in liver biopsies of PiZZ α1-antitrypsin children with different clinical courses, International Journal of Molecular Sciences 24(3).
- Sissingh, N.J.; Vries, B.A. de; Inderson, A.; Hoek, B. van; Heide, F. van der & Hooft, J.E. van (2023), Intraductal fully covered self-expandable metal stent versus multiple plastic stents for treating biliary anastomotic strictures after liver transplantation, Gastrointestinal Endoscopy 97(4): 704-714.
- Fischer, S.E.; Vries, E.S. de; Tushuizen, M.E.; Boer, Y.S. de; Meer, A.J.P. van der; Man, R.A. de; Brouwer, J.T.; Kuyvenhoven, J.P.; Klemt-Kropp, M.; Gevers, T.J.G.; Tjwa, E.T.T.L.; Kuiper, E.M.M.; Verhagen, M.A.M.T.; Friederich, P.W. & Hoek, B. van (2023), Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis, Liver International 43(4).
- Hoogwater, F.J.H.; Kuipers, H.; Meijer, V.E. de; Maulat, C.; Muscari, F.; Polak, W.G.; Hoek, B. van; Jezequel, C.; Alwayn, I.P.J.; Ijzermans, J.N.M.; Mohkam, K.; Mabrut, J.Y.; Vilsteren, F.G.I. van; Adam, J.P.; Chiche, L.; Chebaro, A.; Boleslawski, E.; Dubbeld, J.; Murad, S.D.; Rayar, M. & Porte, R.J. (2023), Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma, BJS Open 7(2).
- Ruijter, B.N.; Tushuizen, M.E.; Helm, D. van der; Hew, M.; Reeven, M.; Vossen, A.C.T.M.; Metselaar, H.J.; Alwayn, I.P.J.; Dubbeld, J.; Polak, W.G. & Hoek, B. van (2023), Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults, Liver Transplantation 30(6).
- Hoek, B. van (2023), Defining the value of extracorporeal liver support in acute and acute-on-chronic liver failure, JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY 11(3).
- Alblas, G.; Lamb, H.J.; Rosendaal, F.R.; Hoek, B. van; Coenraad, M.J. & Mutsert, R. de (2023), Prevalence of non-alcoholic fatty liver in the general Dutch population and in groups at increased risk, Nutrition, Metabolism & Cardiovascular Diseases 33(12): 2497-2507.
- Bot, D.; Klerks, S.; Leistra, E.; Tushuizen, M.E. & Hoek, B. van (2023), Association between skeletal muscle index prior to liver transplantation and 1-year mortality posttransplant, Journal of Parenteral and Enteral Nutrition 47(7).
- Ruijter, B.N.; Inderson, A.; Berg, A.P. van den; Metselaar, H.J.; Dubbeld, J.; Tushuizen, M.E.; Porte, R.J.; Polak, W.; Helm, D. van der; Reeven, M. van; Rodriguez-Girondo, M. & Hoek, B. van (2023), Randomized trial of ciclosporin with 2-h monitoring vs. tacrolimus with trough monitoring in liver transplantation, JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY 11(4).
- Ruijter, B.N.; Wolterbeek, R.; Hew, M.; Reeven, M. van; Helm, D. van der; Dubbeld, J.; Tushuizen, M.E.; Metselaar, H.; Vossen, A.C.T.M. & Hoek, B. van (2023), Epstein-Barr Viral load monitoring strategy and the risk for posttransplant lymphoproliferative disease in adult liver transplantation, Annals of Internal Medicine.
- Stoelinga, A.; Vries, E. de; Tushuizen, M.; Stattermayer, A.; Verhelst, X. & Hoek, B. van (2022), Enhanced liver fibrosis score correlates with transient elastography in patients with treated autoimmune hepatitis, Journal of Hepatology 77: S307-S308.
- Visseren, T.; Erler, N.S.; Heimbach, J.K.; Eaton, J.E.; Selzner, N.; Gulamhusein, A.; Heide, F. van der; Porte, R.J.; Hoek, B. van; Alwayn, I.P.J.; Metselaar, H.J.; IJzermans, J.N.M. & Murad, S.D. (2022), Inflammatory conditions play a role in recurrence of PSC after liver transplantation, JHEP Reports 4(12).
- Golen, R.F. van; Waard, N.E. de; Moolenaar, L.R.; Inderson, A.; Crobach, S.; Langers, A.M.J.; Hoek, B. van & Tushuizen, M.E. (2022), Acute liver injury and acute liver failure following bariatric surgery, Case Reports in Gastroenterology 16(1): 240-246.
- Biewenga, M.; Heidt, S.; Vergunst, M.; Marijnissen, C.M.J.; Man, R.A.D.; Eijk, A.A.V.; Meer, A.J.V.; Trouw, L.A. & Hoek, B.V. (2022), B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis, JHEP Reports 4(5).
- Goudsmit, B.J.; Putter, H. & Hoek, B. van (2022), The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
- Ruijter, B.N.; Tushuizen, M.E.; Moes, D.J.A.R.; Klerk, B.M. de & Hoek, B. van (2022), Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring, Clinical Transplantation 36(12).
- Colapietro, F.; Maisonneuve, P.; Lytvyak, E.; Beuers, U.; Verdonk, R.; Meer, A. van der; Hoek, B. van; Kuiken, S.; Brouwer, H.; Wouden, E.J. van der; Aghemo, A.; Berg, A. van den; Dalekos, G.; Robles-Díaz, M.; Andrade, R.J.; Montano-Loza, A.J.; Brand, F.F. van den; Macedo, G.; Liberal, R.; Boer, Y. de & Lleo, A. (2022), Incidence and predictors of hepatocellular carcinoma development in patients with autoimmune hepatitis: a multicenter international study, Journal of Hepatology 77: S93-S94.
- Biewenga, M.; Verhelst, X.; Baven-Pronk, M.; Putter, H.; Berg, A. van den; Colle, I.; Schouten, J.; Sermon, F.; Steenkiste, C. van; Vlierberghe, H. van; Meer, A. van der; Hoek, B. van & Dutch Autoimmune Hepatitis Study Group (2022), Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1, Clinical Gastroenterology and Hepatology 20(8): 1776-+.
- Ponthier, L.; Marquet, P.; Moes, D.J.A.R.; Rostaing, L.; Hoek, B. van; Monchaud, C.; Labriffe, M. & Woillard, J.B. (2022), Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation, European Journal of Clinical Pharmacology 79.
- Snijders, R.J.A.L.M.; Stoelinga, A.E.C.; Gevers, T.J.G.; Pape, S.; Biewenga, M.; Verdonk, R.C.; Jonge, H.J.M. de; Vrolijk, J.M.; Bakker, S.F.; Vanwolleghem, T.; Boer, Y.S. de; Pronk, M.A.M.C.B.; Beuers, U.H.W.; Meer, A.J. van der; Gerven, N.M.F. van; Sijtsma, M.G.M.; Verwer, B.J.; Gisbertz, I.A.M.; Bartelink, M.; Brand, F.F. van den; Korkmaz, K.S.; Berg, A.P. van den; Guichelaar, M.M.J.; Soufidi, K.; Levens, A.D.; Hoek, B. van; Drenth, J.P.H. & Dutch Autoimmune Hepatitis Working (2022), Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial, Trials 23(1).
- Visseren, T.; Erler, N.S.; Heimbach, J.K.; Eaton, J.E.; Selzner, N.; Gulamhusein, A.; Heide, F. van der; Porte, R.J.; Hoek, B. van; Alwayn, I.P.J.; Metselaar, H.J.; IJzermans, J.N.M. & Murad, S.D. (2022), Inflammatory conditions play a role in recurrence of PSC after liver transplantation, JHEP Reports 4(12).
- Meucci, M.C.; Strating, M.M.H.; Butcher, S.C.; Rijswijk, C.S.P. van; Hoek, B. van; Delgado, V.; Bax, J.J.; Tushuizen, M.E. & Marsan, N.A. (2022), Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt, Hepatology Communications 6(11).
- Baven-Pronk, M.A.M.C.; Hew, J.M.; Biewenga, M.; Tushuizen, M.E.; Berg, A.P. van den; Bouma, G.; Brouwer, J.T.; Hoek, B. van & Dutch Autoimmune Hepatitis Study G (2022), Calcineurin inhibitors in the treatment of adult autoimmune hepatitis, JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY 10(6).
- Ruijter, B.N.; Tushuizen, M.E.; Moes, D.J.A.R.; Klerk, B.M. de & Hoek, B. van (2022), Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring, Clinical Transplantation 36(12).
- Biewenga, M.; Verhelst, X.; Baven-Pronk, M.; Putter, H.; Berg, A. van den; Colle, I.; Schouten, J.; Sermon, F.; Steenkiste, C. van; Vlierberghe, H. van; Meer, A. van der; Hoek, B. van & Dutch Autoimmune Hepatitis Study G (2022), Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1, Clinical Gastroenterology and Hepatology 20(8): 1776-+.
- Montano-Loza, A.J.; Ronca, V.; Ebadi, M.; Hansen, B.E.; Hirschfield, G.; Elwir, S.; Alsaed, M.; Milkiewicz, P.; Janik, M.K.; Marschall, H.U.; Burza, M.A.; Efe, C.; Caliskan, A.R.; Harputluoglu, M.; Kabacam, G.; Terrabuio, D.; Onofrio, F.D.; Selzner, N.; Bonder, A.; Pares, A.; Llovet, L.; Akyildiz, M.; Arikan, C.; Manns, M.P.; Taubert, R.; Weber, A.L.; Schiano, T.D.; Haydel, B.; Czubkowski, P.; Socha, P.; Oldak, N.; Akamatsu, N.; Tanaka, A.; Levy, C.; Martin, E.F.; Goel, A.; Sedki, M.; Jankowska, I.; Ikegami, T.; Rodriguez, M.; Sterneck, M.; Weiler-Normann, C.; Schramm, C.; Donato, M.F.; Lohse, A.; Andrade, R.J.; Patwardhan, V.R.; Hoek, B. van; Biewenga, M.; Kremer, A.E.; Ueda, Y.; Deneau, M.; Pedersen, M.; Mayo, M.J.; Floreani, A.; Burra, P.; Secchi, M.F.; Beretta-Piccoli, B.T.; Sciveres, M.; Maggiore, G.; Jafri, S.M.; Debray, D.; Girard, M.; Lacaille, F.; Lytvyak, E.; Mason, A.L.; Heneghan, M.; Oo, Y.H. & Int Autoimmune Hepatitis Grp IAIHG (2022), Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation, Journal of Hepatology 77(1): 84-97.
- Baven-Pronk, M.A.M.C.; Hew, J.M.; Biewenga, M.; Tushuizen, M.E.; Berg, A.P. van den; Bouma, G.; Brouwer, J.T.; Hoek, B. van & Dutch Autoimmune Hepatitis Study G (2022), Calcineurin Inhibitors in the Treatment of Adult Autoimmune Hepatitis: A Systematic Review, JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY 10(6): 1155-1166.
- Goudsmit, B.J.; Putter, H.; Tushuizen, M.E.; Vogelaar, S.; Pirenne, J.; Alwayn, I.P.J.; Hoek, B. van & Braat, A.E. (2021), Refitting the model for end-stage liver disease for the Eurotransplant region, Hepatology 74(1).
- Bot, D.; Droop, A.; Lucassen, C.J.; Veen, M.E. van; Vugt, J.L. van; Feshtali, S.S.; Leistra, E.; Tushuizen, M.E. & Hoek, B. van (2021), Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease, Clinical Nutrition ESPEN 42: 272-279.
- Martial, L.C.; Biewenga, M.; Ruijter, B.N.; Keizer, R.; Swen, J.J.; Hoek, B. van & Moes, D.J.A.R. (2021), Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients, British Journal of Clinical Pharmacology 87(11).
- Schlegel, A.; Reeven, M. van; Croome, K.; Parente, A.; Dolcet, A.; Widmer, J.; Meurisse, N.; Carlis, R. de; Hessheimer, A.; Jochmans, I.; Mueller, M.; Leeuwen, O.B. van; Nair, A.; Tomiyama, K.; Sherif, A.; Elsharif, M.; Kron, P.; Helm, D. van der; Borja-Cacho, D.; Bohorquez, H.; Germanova, D.; Dondossola, D.; Olivieri, T.; Camagni, S.; Gorgen, A.; Patrono, D.; Cescon, M.; Croome, S.; Panconesi, R.; Carvalho, M.F.; Ravaioli, M.; Caicedo, J.C.; Loss, G.; Lucidi, V.; Sapisochin, G.; Romagnoli, R.; Jassem, W.; Colledan, M.; Carlis, L. de; Rossi, G.; Benedetto, F.D.; Miller, C.M.; Hoek, B. van; Attia, M.; Lodge, P.; Hernandez-Alejandro, R.; Detry, O.; Quintini, C.; Oniscu, G.C.; Fondevila, C.; Malago, M.; Pirenne, J.; IJzermans, J.N.M.; Porte, R.J.; Dutkowski, P.; Taner, C.B.; Heaton, N.; Clavien, P.A.; Polak, W.G. & Muiesan, P. (2021), A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation, Journal of Hepatology 76(2).
- Isfordink, C.J.; Laar, T.J.W. van de; Rebers, S.P.H.; Wessels, E.; Molenkamp, R.; Knoester, M.; Baak, B.C.; Nieuwkoop, C. van; Hoek, B. van; Brakenhoff, S.M.; Blokzijl, H.; Arends, J.E.; Valk, M. van der & Schinkel, J. (2021), Direct-acting antiviral treatment for hepatitis C genotypes uncommon in high-income countries, Open Forum Infectious Diseases 8(2).
- Goudsmit, B.F.J.; Tushuizen, M.E.; Putter, H.; Braat, A.E. & Hoek, B. van (2021), The role of the model for end-stage liver disease-sodium score and joint models for 90-day mortality prediction in patients with acute-on-chronic liver failure.
- Jong, L.A. de; Schoonhoven, A.V. van; Hofstra, H.S.; Postma, M.J. & Hoek, B. van (2021), Budget impact of optimizing rifaximin-alpha use for the prevention of recurrent hepatic encephalopathy in The Netherlands, Journal of Medical Economics (JME) 24(1): 1149-1163.
- Biewenga, M.; Kooij, M.K. van der; Wouters, M.W.J.M.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Groot, J.W.B. de; Boers-Sonderen, M.J.; Hospers, G.A.P.; Piersma, D.; Rijn, R.S. van; Suijkerbuijk, K.P.M.; Tije, A.J. ten; Veldt, A.A.M. van der; Vreugdenhil, G.; Haanen, J.B.A.G.; Eertwegh, A.J.M. van der; Hoek, B. van & Kapiteijn, E. (2021), Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients, Hepatology International 15(2): 510-519.
- Annema, C.; Venema, A.; Metselaar, H.; Hoek, B. van; Porte, R.J. & Ranchor, A. (2021), POSTTRAUMATIC GROWTH IN LIVER TRANSPLANT RECIPIENTS: RESULT OF A PROSPECTIVE COHORT STUDY, Transplant International 34: 80-80.
- Broekhoven, A.G.C.; Fiocco, M.; Sprengers, D.; Takkenberg, R.B.; Meer, S. van; Erpecum, K.J. van; Ramsoekh, D.; Verspaget, H.W.; Burgmans, M.C.; Osanto, S.; Baranski, A.G.; Hoek, B. van & Coenraad, M.J. (2021), Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma, European Journal of Internal Medicine 97.
- Biewenga, M.; Martial, L.C.; Ruijter, B.N.; Swen, J.J.; Moes, D.J.A.R. & Hoek, B. van (2021), Population pharmacokinetics of meltdose tacrolimus (Envarsus (R)) in stable adult liver transplant recipients, Transplantation 105(8): 30-30.
- Montano-Loza, A.J.; Ronca, V.; Ebadi, M.; Hansen, B.; Hirschfield, G.; Elwir, S.; Alsaed, M.; Milkiewicz, P.; Janik, M.K.; Marschall, H.U.; Burza, M.A.; Efe, C.; Caliskan, A.R.; Harputluoglu, M.; Kabacam, G.; Terrabuio, D.R.; Onofrio, F.; Pares, A.; Llovet, L.P.; Akyildiz, M.; Arikan, C.; Manns, M.P.; Taubert, R.; Weber, A.L.; Schiano, T.; Hayde, B.; Czubkowski, P.; Socha, P.; Oldak, N.; Akamatsu, N.; Tanaka, A.; Levy, C.; Martin, E.F.; Goel, A.; Sedki, M.; Jankowska, I.; Ikegami, T.; Rodriguez, M.; Sterneck, M.; Weiler-Normann, C.; Schramm, C.; Donato, M.F.; Lohse, A.W.; Andrade, R.J.; Bonder, A.; Patwardhan, V.; Hoek, B. van; Biewenga, M.; Kremer, A.E.; Ueda, Y.; Deneau, M.; Pedersen, M.; Mayo, M.J.; Floreani, A.; Burra, P.; Secchi, M.F.; Beretta-Piccoli, B.T.; Sciveres, M.; Maggiore, G.; Jafri, S.M.; Debray, D.; Girard, M.; Lacaille, F.; Lytvyak, E.; Mason, A.L.; Heneghan, M. & Oo, Y.H. (2021), Multicentre international evaluation of autoimmune hepatitis and liver transplantation: disease recurrence is associated with recipient features, type of immunosuppression and impaired outcomes, Journal of Hepatology 75: S193-S194.
- Biewenga, M.; Verhelst, X.P.D.M.J.; Baven-Pronk, M.A.M.C.; Putter, H.; Berg, A.P. van den; Nieuwkerk, K.C.M.J. van; Buuren, H.R. van; Bouma, G.; Boer, Y.S. de; Simoen, C.; Colle, I.; Schouten, J.; Sermon, F.; Steenkiste, C. van; Vlierberghe, H. van; Meer, A.J. van der; Nevens, F.; Hoek, B. van & Dutch Autoimmune Hepatitis Study G (2021), Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1, United European Gastroenterology Journal 9(6): 662-671.
- Guichelaar, M. & Hoek, B. van (2021), Obituary: a pioneer in transplantation: a tribute to Professor Chris Gips (18 February 1932-29 July 2020), Journal of Hepatology 74(3): 763-763.
- Rijn, R. van; Schurink, I.; Cerisuelo, M.C.; Haas, R.J. de; Heaton, N.; Hoek, B. van; Huurman, V.; Jochmans, I.; Leeuwen, O.B. van; Meijer, V.E. de; Monbaliu, D.; Troisi, R.; Vanlander, A.; Jonge, J. de & Porte, R.J. (2021), A RANDOMIZED CONTROLLED TRIAL OF DUAL HYPOTHERMIC OXYGENATED MACHINE PERFUSION IN DONATION AFTER CIRCULATORY DEATH LIVER TRANSPLANTATION, Transplant International 34: 53-53.
- Dijk, M. van; Brakenhoff, S.M.; Isfordink, C.J.; Cheng, W.H.; Blokzijl, H.; Boland, G.; Dofferhoff, A.S.M.; Hoek, B. van; Nieuwkoop, C. van; Sonneveld, M.J.; Valk, M. van der; Drenth, J.P.H. & Knegt, R.J. de (2021), The Netherlands is on track to meet the World Health Organization hepatitis C elimination targets by 2030, Journal of Clinical Medicine 10(19).
- Biewenga, M.; Heidt, S.; Vergunst, M.; Marijnissen, C.; Meer, A. van der; Man, R. de; Eijk, A. van der; Trouw, L. & Hoek, B. van (2021), Circulating B-cell activating factor of the tumour necrosis family (BAFF) and interleukin 21 levels predict treatment response in patients with autoimmune hepatitis, Journal of Hepatology 75: S428-S428.
- Mulder, M.; Murad, S.D.; Busschbach, J.; Verhey, E.; Jong, K. de; Berg, A.A.P. van den; Hoek, B. van; Alwayn, I.; Erler, N.; Polak, W.; Winter, B. de; Hoed, C. den & Metselaar, H. (2021), QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY, Transplant International 34: 169-170.
- Goudsmit, B.J.; Braat, A.E.; Tushuizen, M.E.; Vogelaar, S.; Pirenne, J.; Alwayn, I.P.J.; Hoek, B. & Putter, H. (2021), Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease, American Journal of Transplantation 21(11).
- Isfordink, C.J.; Laar, T.J.W. van de; Rebers, S.P.H.; Wessels, E.; Molenkamp, R.; Knoester, M.; Baak, B.C.; Nieuwkoop, C. van; Hoek, B. van; Brakenhoff, S.M.; Blokzijl, H.; Arends, J.E.; Valk, M. van der; Schinkel, J. & HepNed Study Grp (2021), Direct-acting antiviral treatment for hepatitis C genotypes uncommon in high-income countries, Open Forum Infectious Diseases 8(8).
- Karkampouna, S.; Helm, D. van der; Scarpa, M.; Hoek, B. van; Verspaget, H.W.; Goumans, M.J.; Coenraad, M.J.; Kruithof, B.P.T. & Julio, M.K.D. (2021), Oncofetal protein CRIPTO is involved in wound healing and fibrogenesis in the regenerating liver and is associated with the initial stages of cardiac fibrosis, Cells 10(12).
- Goudsmit, B.J.; Braat, A.E.; Tushuizen, M.E.; Coenraad, M.J.; Vogelaar, S.; Alwayn, I.P.J.; Hoek, B. van & Putter, H. (2021), Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure, JHEP Reports 3(6).
- Visseren, T.; Erler, N.S.; Polak, W.G.; Adam, R.; Karam, V.; Vondran, F.W.R.; Ericzon, B.G.; Thorburn, D.; IJzermans, J.N.M.; Paul, A.; Heide, F. van der; Taimr, P.; Nemec, P.; Pirenne, J.; Romagnoli, R.; Metselaar, H.J.; Murad, S.D. & European Liver Intestine Transplan (2021), Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond, Transplant International 34(8): 1455-1467.
- Mulder, M.; Murad, S.D.; Jong, K. de; Berg, A.A.P. van den; Hoek, B. van; Alwayn, I.; Erler, N.; Polak, W.; Winter, B. de; Hoed, C. den & Metselaar, H. (2021), COMPARING RENAL FUNCTION IN LT RECIPIENTS WITH LOW-DOSE TACROLIMUS AND SIROLIMUS VERSUS NORMAL-DOSE TACROLIMUS, A MULTICENTER RCT; 24-MONTH RESULTS, Transplant International 34: 170-170.
- Rijn, R. van; Schurink, I.J.; Vries, Y. de; Berg, A.P. van den; Cerisuelo, M.C.; Murad, S.D.; Erdmann, J.I.; Gilbo, N.; Haas, R.J. de; Heaton, N.; Hoek, B. van; Huurman, V.A.L.; Jochmans, I.; Leeuwen, O.B. van; Meijer, V.E. de; Monbaliu, D.; Polak, W.G.; Slangen, J.J.G.; Troisi, R.I.; Vanlander, A.; Jonge, J. de; Porte, R.J. & DHOPE DCD Trial Investigators (2021), Hypothermic machine perfusion in liver transplantation, New England Journal of Medicine 384(15): 1391-1401.
- Bot, D.; Inderson, A.; Coenraad, M.; Hoek, B. van & Tushuizen, M. (2021), SEMAGLUTIDE IS A SAFE AND EFFECTIVE TREATMENT IN PATIENTS AFTER LIVER TRANSPLANTATION WITH POST-TRANSPLANT DIABETES MELLITUS, Transplant International 34: 120-120.
- Annema, C.; Metselaar, H.; Hoek, B. van; Porte, R.J. & Ranchor, A. (2021), THE ASSOCIATION OF TRAJECTORIES OF DEPRESSION AND ANXIETY ON OUTCOMES AT THE LONG TERM AFTER LIVER TRANSPLANTATION, Transplant International 34: 35-36.
- Isfordink, C.J.; Laar, T.J.W. van de; Rebers, S.P.H.; Wessels, E.; Molenkamp, R.; Knoester, M.; Baak, B.C.; Nieuwkoop, C. van; Hoek, B. van; Brakenhoff, S.M.; Blokzijl, H.; Arends, J.E.; Valk, M. van der; Schinkel, J. & HepNed Study Grp (2021), Erratum to: Direct-acting antiviral treatment for hepatitis C genotypes uncommon in high-income countries, Open Forum Infectious Diseases 8(8).
- Meinderts, J.; Metselaar, H.; Hoed, C. den; Rijntjes, D.; Hoek, B. van; Groenewout, M.; Prins, J.; Berger, S.; Berg, A.A.P. van den & Jong, M. de (2021), SHORT- AND LONG-TERM PREGNANCY OUTCOMES AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN THE NETHERLANDS, Transplant International 34: 116-116.
- Biewenga, M.; Inderson, A.; Tushuizen, M.E.; Crobach, A.S.L.P. & Hoek, B. van (2020), Early predictors of short-term prognosis in acute and acute severe autoimmune hepatitis, Liver Transplantation 26(12).
- Bruggenwirth, I.M.A.; Reeven, M. van; Vasiliauskaite, I.; Helm, D. van der; Hoek, B. van; Schaapherder, A.F.; Alwayn, I.P.J.; Berg, A.P. van den; Meijer, V.E. de; Murad, S.D.; Polak, W.G. & Porte, R.J. (2020), Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation, Transplant International 34(1).
- Schnitzbauer, A.A.; Filmann, N.; Adam, R.P.; Bachellier, P.; Bechstein, W.O.; Becker, T.; Bhoori, S.; Bilbao, I.; Brockmann, J.; Burra, P.; Chazoullieres, O.; Cillo, U.; Colledan, M.; Duvoux, C.; Ganten, T.M.; Gugenheim, J.; Heise, M.; Hoek, B. van; Jamieson, N.; Jong, K.P. de; Klein, C.G.; Klempnauer, J.; Kneteman, N.; Lerut, J.; Makisalo, H.; Mazzaferro, V.; Mirza, D.F.; Nadalin, S.; Neuhaus, P.; Pageaux, G.P.; Pinna, A.D.; Pirenne, J.; Pratschke, J.; Powel, J.; Rentsch, M.; Rizell, M.; Rossi, G.; Rostaing, L.; Roy, A.P.; Scholz, T.; Settmacher, U.; Soliman, T.; Strasser, S.; Soderdahl, G.; Troisi, R.I.; Turrion, V.S.; Schlitt, H.J. & Geissler, E.K. (2020), mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors, Annals of Surgery 272(5): 855-862.
- Takagi, K.; Domagala, P.; Porte, R.J.; Alwayn, I.; Metselaar, H.J.; Berg, A.P. van den; Hoek, B. van; Ijzermans, J.N.M. & Polak, W.G. (2020), Liver retransplantation in adult recipients, Journal of Hepato-Biliary-Pancreatic Sciences 27(1): 26-33.
- Hoek, B. van (2020), Editorial: genome-wide association studies for developing chronic hepatitis B, Alimentary Pharmacology and Therapeutics 52(6): 1083-1084.
- Reeven, M. van; Gilbo, N.; Monbaliu, D.; Leeuwen, O.B. van; Porte, R.J.; Ysebaert, D.; Hoek, B. van; Alwayn, I.P.J.; Meurisse, N.; Detry, O.; Coubeau, L.; Cicarelli, O.; Berrevoet, F.; Vanlander, A.; IJzermans, J.N.M. & Polak, W.G. (2020), Evaluation of liver graft donation after euthanasia, JAMA Surgery 155(10): 917-924.
- Pape, S.; Gevers, T.J.G.; Vrolijk, J.M.; Hoek, B. van; Bouma, G.; Nieuwkerk, C.M.J. van; Taubert, R.; Jaeckel, E.; Manns, M.P.; Papp, M.; Sipeki, N.; Stickel, F.; Efe, C.; Ozaslan, E.; Purnak, T.; Nevens, F.; Kessener, D.J.N.; Kahraman, A.; Wedemeyer, H.; Hartl, J.; Schramm, C.; Lohse, A.W.; Drenth, J.P.H. & Heneghan, M.A. (2020), Rapid response to treatment of autoimmune hepatitis associated with remission at 6 and 12 months, Clinical Gastroenterology and Hepatology 18(7): 1609-+.
- Dekkers, N.; Meeteren, M.W. van; Wolterbeek, R.; Sarasqueta, A.F.; Laleman, W.; Inderson, A.; Desschans, B.; Hoek, B. van; Korkmaz, K.S.; Vermeire, S. & Maljaars, J. (2020), Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis?, Digestive and Liver Disease 52(5): 528-533.
- Goudsmit, B.F.J.; Putter, H.; Tushuizen, M.E.; Boer, J. de; Vogelaar, S.; Alwayn, I.P.J.; Hoek, B. van & Braat, A.E. (2020), Invited response to "MELD calibration", American Journal of Transplantation.
- Reeven, M. van; Leeuwen, O.B. van; Helm, D. van der; Murad, S.D.; Berg, A.P. van den; Hoek, B. van; Alwayn, I.P.J.; Polak, W.G. & Porte, R.J. (2020), Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study, Transplant International 33(6): 667-674.
- Goudsmit, B.J.; Putter, H.; Tushuizen, M.E.; Boer, J. de; Vogelaar, S.; Alwayn, I.P.J.; Hoek, B. van & Braat, A.E. (2020), Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region, American Journal of Transplantation 21(1).
- Jansen, J.C.; Hoek, B. van; Metselaar, H.J.; Berg, A.P. van den; Zijlstra, F.; Huijben, K.; Scherpenzeel, M. van; Drenth, J.P.H. & Lefeber, D.J. (2020), Screening for abnormal glycosylation in a cohort of adult liver disease patients, Journal of Inherited Metabolic Disease 43(6).
- Leeuwen, O.B. van; Reeven, M. van; Helm, D. van der; IJzermans, J.N.M.; Meijer, V.E. de; Berg, A.P. van den; Murad, S.D.; Hoek, B. van; Alwayn, I.P.J.; Porte, R.J. & Polak, W.G. (2020), Donor hepatectomy time influences ischemia-reperfusion injury of the biliary tree in donation after circulatory death liver transplantation, Surgery 168(1): 160-166.
- Pape, S.; Gevers, T.J.G.; Vrolijk, J.M.; Hoek, B. van; Bouma, G.; Nieuwkerk, C.M.J. van; Taubert, R.; Jaeckel, E.; Manns, M.P.; Papp, M.; Sipeki, N.; Stickel, F.; Efe, C.; Ozaslan, E.; Purnak, T.; Nevens, F.; Kessener, D.J.N.; Kahraman, A.; Wedemeyer, H.; Hartl, J.; Schramm, C.; Lohse, A.W.; Heneghan, M.A. & Drenth, J.P.H. (2020), High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation, Liver International 40(9): 2164-2171.
- Biewenga, M.; Sarasqueta, A.F.; Tushuizen, M.E.; Jonge-Muller, E.S.M. de; Hoek, B. van & Trouw, L.A. (2020), The role of complement activation in autoimmune liver disease, Autoimmunity Reviews 19(6).
- Goudsmit, B.F.; Putter, H.; Hoek, B. van & Braat, A.E. (2020), Validation of the Model for End-Stage Liver Disease Sodium Score in the Eurotransplant Region, American Journal of Transplantation 20: 1088-1088.
- Mensink, J.W.; Hoek, B. van; Schaefer, B.; Rosmalen, M.D. van; Alwayn, P. & Braat, A.E. (2020), Transplanting Livers from Hepatitis C Virus Positive Donors; Is it Worth the Risk?, American Journal of Transplantation 20: 582-582.
- Biewenga, M.; Verhelst, X.; Baven-Pronk, M.; Putter, H.; Berg, A.P. van den; Colle, I.; Schouten, J.; Sermon, F.; Steenkiste, C. van; Vlierberghe, H. van; Meer, A.J. van der; Hoek, B. van & Dutch Autoimmune Hepatitis Study (2020), ALANINE AMINOTRANSFERASE DURING TREATMENT PREDICTS LONG-TERM SURVIVAL IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE 1, Hepatology 72: 736A-737A.
- Takagi, K.; Domagala, P.; Porte, R.J.; Alwayn, I.; Metselaar, H.J.; Berg, A.P. van den; Hoek, B. van; Ijzermans, J.N.M. & Polak, W.G. (2020), Liver retransplantation in adult recipients, Journal of Hepato-Biliary-Pancreatic Sciences 27(1): 26-33.
- Boer, J.D. de; Braat, A.E.; Putter, H.; Vries, E. de; Strassburg, C.H.; Mathe, Z.; Hoek, B. van; Braun, F.; Berg, A.P. van den; Mikulic, D.; Michielsen, P.; Trotovsek, B.; Zoller, H.; Boer, J. de; Rosmalen, M.D. van; Samuel, U.; Berlakovich, G.; Guba, M. & ELIAC (2019), Outcome of Liver Transplant Patients With High Urgent Priority: Are We Doing the Right Thing?, Transplantation 103(6): 1181-1190.
- Brand, F.F. van den; Veen, K.S. van der; Boer, Y.S. de; Gerven, N.M. van; Lissenberg-Witte, B.I.; Beuers, U.; Erpecum, K.J. van; Buuren, H.R. van; Ouden, J.W. den; Brouwer, J.T.; Vrolijk, J.M.; Verdonk, R.C.; Hoek, B. van; Koek, G.H.; Drenth, J.P.H.; Guichelaar, M.M.J.; Mulder, C.J.J.; Bloemena, E.; Nieuwkerk, C.M.J. van; Bouma, G. & Dutch Autoimmune Hepatitis Study G (2019), Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis, Clinical Gastroenterology and Hepatology 17(5): 940-+.
- Steenstraten, I.C.; Korkmaz, K.S.; Trivedi, P.J.; Inderson, A.; Hoek, B. van; Girondo, M.D.M.R. & Maljaars, P.W.J. (2019), Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation, Alimentary Pharmacology and Therapeutics 49(6): 636-643.
- Dijk, M. van; Kracht, P.A.M.; Arends, J.E.; Blokzijl, H.; Burger, D.M.; Erpecum, K.J. van; Hoek, B. van; Knegt, R.J. de; Posthouwer, D.; Ramsoekh, D.; Rijnders, B.J.A.; Schinkel, J.; Willemse, S.B.; Valk, M. van der; Drenth, J.P.H. & HepNed Study Grp (2019), Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project, Netherlands Journal of Medicine 77(4): 131-138.
- Pape, S.; Gevers, T.J.G.; Belias, M.; Mustafajev, I.F.; Vrolijk, J.M.; Hoek, B. van; Bouma, G.; Nieuwkerk, C.M.J. van; Hartl, J.; Schramm, C.; Lohse, A.W.; Taubert, R.; Jaeckel, E.; Manns, M.P.; Papp, M.; Stickel, F.; Heneghan, M.A. & Drenth, J.P.H. (2019), Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis, Clinical Gastroenterology and Hepatology 17(10): 2068-+.
- Boer, J.D. de; Putter, H.; Blok, J.J.; Alwayn, I.P.J.; Hoek, B. van & Braat, A.E. (2019), Predictive Capacity of Risk Models in Liver Transplantation, Transplantation Direct 5(6).
- Nuland, M. van; Janssen, J.M.; Hoek, B. van; Rosing, H.; Beijnen, J.H. & Bergman, A.M. (2019), Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant, Clinical Genitourinary Cancer 17(5): E893-E896.
- Lam, H.D.; Pas, S.L. van der; Baranski, A.; Hoek, B. van; Burgmans, M.C.; Bennink, R.J. & Geus-Oei, L.F. de (2019), The role of proportionate kinetic growth rate fraction in future remnant liver function over volume determined by Tc-99m-Mebrofenin hepatobiliary scintigraphy including SPELT and computed tomography in the risk prediction of postoperative mortality in ALPPS, Surgery 165(6): 1244-1245.
- Brand, F.F. van den; Veen, K.S. van der; Lissenberg-Witte, B.I.; Boer, Y.S. de; Hoek, B. van; Drenth, J.P.H.; Verdonk, R.C.; Vrolijk, J.M.; Nieuwkerk, C.M.J. van; Bouma, G.; Gerven, N.M. van; Kuijvenhoven, J.P.; Schreuder, T.C.M.A.; Wouden, E.J. van der; Meyel, J.J.M. van; Baak, L.C.; Stadhouders, P.H.G.M.; Klemt-Kropp, M.; Verhagen, M.A.M.T.; Bhalla, A.; Ouden, J.W. den; Beuers, U.; Erpecum, K.J. van; Buuren, H.R. van; Brouwer, J.T. & Dutch Autoimmune Hepatitis Study G (2019), Adverse events related to low dose corticosteroids in autoimmune hepatitis, Alimentary Pharmacology and Therapeutics 50(10): 1120-1126.
- Boer, Y.S. de; Gerussi, A.; Brand, F.F. van den; Wong, G.W.; Halliday, N.; Liberal, R.; Drenth, J.P.H.; Thorburn, D.; Bouma, G.; Heneghan, M.A.; Gerven, N.M. van; Beuers, U.; Erpecum, K.J. van; Buuren, H.R. van; Ouden, J.W. den; Brouwer, J.T.; Vrolijk, J.M.; Verdonk, R.C.; Hoek, B. van; Koek, G.H.; Guichelaar, M.M.J.; Bloemena, E.; Nieuwkerk, C.M.J. van; Schreuder, T.C.M.A.; Wouden, E.J. van der; Meyel, J.J.M. van; Baak, L.C.; Stadhouders, P.H.G.M.; Klemt-Kropp, M.; Verhagen, M.A.M.T.; Bhalla, A.; Kuijvenhoven, J.P. & Dutch Autoimmune Hepatitis Study G (2019), Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis, Clinical Gastroenterology and Hepatology 17(8): 1616-+.
- Pietersen, L.C.; Hoek, B. van & Braat, A.E. (2019), Comment on "The role of graft reperfusion sequence in the development of non-anastomotic biliary strictures following orthotopic liver transplantation: A meta-analysis".
- Boer, J.D. de; Blok, J.J.; Putter, H.; Koopman, J.J.E.; Hoek, B. van; Samuel, U.; Rosmalen, M. van; Metselaar, H.J.; Alwayn, I.P.J.; Guba, M.; Braat, A.E. & Eurotransplant Liver Intestine (2019), Optimizing the Use of Geriatric Livers for Transplantation in the Eurotransplant Region, Liver Transplantation 25(2): 260-274.
- Couperus, L.E.; Vliegen, H.W.; Sorgdrager, B.J.; Dulk, A.C. den; Beeres, S.L.M.A.; Sarton, E.Y.; Dubbeld, J.; Schalij, M.J.; Jukema, J.W.; Hoek, B. van & Scherptong, R.W.C. (2019), Prognostic Importance of Increased Right Ventricular Afterload in Orthotopic Liver Transplantation Recipients With Endstage Cirrhosis, Heart, Lung and Circulation 28(6): 893-900.
- Rijn, R. van; Berg, A.P. van den; Erdmann, J.I.; Heaton, N.; Hoek, B. van; Jonge, J. de; Leuvenink, H.G.D.; Mahesh, S.V.K.; Mertens, S.; Monbaliu, D.; Muiesan, P.; Perera, M.T.P.R.; Polak, W.G.; Rogiers, X.; Troisi, R.I.; Vries, Y. de & Porte, R.J. (2019), Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial, BMC Gastroenterology 19.
- Pietersen, L.C.; Sarton, E.; Alwayn, I.; Lam, H.D.; Putter, H.; Hoek, B. van & Braat, A.E. (2019), Impact of Temporary Portocaval Shunting and Initial Arterial Reperfusion in Orthotopic Liver Transplantation, Liver Transplantation.
- Helm, D. van der; Barnhoorn, M.C.; Jonge-Muller, E.S.M. de; Molendijk, I.; Hawinkels, L.J.A.C.; Coenraad, M.J.; Hoek, B. van & Verspaget, H.W. (2019), Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers, Journal of Cellular and Molecular Medicine 23(9): 6238-6250.
- Boerekamps, A.; Vanwolleghem, T.; Valk, M. van der; Berk, G.E. van den; Kasteren, M. van; Posthouwer, D.; Dofferhoff, A.S.M.; Hoek, B. van; Ramsoekh, D.; Koopsen, J.; Schinkel, J.; Florence, E.; Arends, J.E. & Rijnders, B.J. (2019), 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study), Journal of Hepatology 70(3): 554-557.
- Boer, J.D. de; Putter, H.; Blok, J.J.; Alwayn, I.P.; Hoek, B. van & Braat, A.E. (2019), A Comparison of the BAR, DRM, DRI, sRRI, ET-DRI, D-MELD and SOFT Score to Predict Outcome after Liver Transplantation in the SRTR Database., American Journal of Transplantation 19: 462-462.
- Visseren, T.; Erler, N.S.; Heimbach, J.K.; Selzner, N.; Gulamhusein, A.; Heide, F. van der; Porte, R.J.; Hoek, B. van; Alwayn, I.P.J.; Walsh, M.; Metselaar, H.J.; IJzermans, J.N.M. & Murad, S.D. (2019), RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS DETERIORATES GRAFT SURVIVAL: AN INTERNATIONAL MULTICENTER STUDY, Transplant International 32: 133-133.
- Reeven, M. van; Gilbo, N.; Monbaliu, D.; Leeuwen, O.B. van; Blokzijl, J.; Porte, R.J.; Meurisse, N.; Detry, O.; Helm, D. van der; Hoek, B. van; Alwayn, I.P.J.; Ciccarelli, O.; Rogiers, X.; Murad, S.D.; IJzermans, J.N.M. & Polak, W.G. (2019), CLINICAL OUTCOMES OF DCD TYPE V LIVER TRANSPLANTATION: DONATION AFTER EUTHANASIA, Transplant International 32: 134-134.
- Bruggenwirth, I.; Reeven, M. van; Vasiliauskaite, I.; Hoek, B. van; Braat, A.; Berg, A. van den; Metselaar, H.; Polak, W. & Porte, R. (2019), Outcome after transplantation of liver grafts from diabetic donors: a national multicenter study, Transplantation 103(8): 371-371.
- Korkmaz, K.S.; Steenstraten, I.; Trivedi, P.; Inderson, A.; Hoek, B. van; Girondo, M.R. & Maljaars, J. (2019), Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis, Journal of Hepatology 70(1): E414-E414.
- Steenstraten, I.; Korkmaz, K.S.; Trivedi, P.; Inderson, A.; Hoek, B. van; Girondo, M.R. & Maljaars, J. (2019), Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis, Journal of Crohn's and Colitis 13: S302-S303.
- Lam, H.D.; Pas, S.L. van der; Baranski, A.; Hoek, B. van; Burgmans, M.C.; Bennink, R.J. & Geus-Oei, L.F. de (2019), The role of proportionate kinetic growth rate fraction in future remnant liver function over volume determined by 99mTc-Mebrofenin hepatobiliary scintigraphy including SPELT and computed tomography in the risk prediction of postoperative mortality in ALPPS, Surgery 165(6): 1244-1245.
- Karkampouna, S.; Helm, D. van der; Gray, P.C.; Chen, L.P.; Klima, I.; Grosjean, J.; Burgmans, M.C.; Farina-Sarasqueta, A.; Snaar-Jagalska, E.B.; Stroka, D.M.; Terracciano, L.; Hoek, B. van; Schaapherder, A.F.; Osanto, S.; Thalmann, G.N.; Verspaget, H.W.; Coenraad, M.J. & Kruithof-de Julio, M. (2018), CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma, Journal of Pathology 245(3): 297-310.
- Baven-Pronk, M.A.M.C.; Biewenga, M.; Silfhout, J.J. van; Berg, A.P. van den; Buuren, H.R. van; Verwer, B.J.; Nieuwkerk, C.M.J. van; Bouma, G. & Hoek, B. van (2018), Role of age in presentation, response to therapy and outcome of autoimmune hepatitis, Clinical and Translational Gastroenterology 9.
- Golen, R.F. van; Reiniers, M.J.; Gorp, J. van; Tushuizen, M.E. & Hoek, B. van (2018), Utilizing Mechanistic Biomarkers in Treating Paracetamol Hepatotoxicity, Hepatology 68(5): 2032-2035.
- Vugt, J.L.A. van; Alferink, L.J.M.; Buettner, S.; Gaspersz, M.P.; Bot, D.; Murad, S.D.; Feshtali, S.; Ooijen, P.M.A. van; Polak, W.G.; Porte, R.J.; Hoek, B. van; Berg, A.P. van den; Metselaar, H.J. & IJzermans, J.N.M. (2018), A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort, Journal of Hepatology 68(4): 707-714.
- Helm, D. van der; Groenewoud, A.; Jonge-Muller, E.S.M. de; Barnhoorn, M.C.; Schoonderwoerd, M.J.A.; Coenraad, M.J.; Hawinkels, L.J.A.C.; Snaar-Jagalska, B.E.; Hoek, B. van & Verspaget, H.W. (2018), Mesenchymal stromal cells prevent progression of liver fibrosis in a novel zebrafish embryo model, Scientific Reports 8.
- Kerbert, A.J.C.; Reverter, E.; Verbruggen, L.; Tieleman, M.; Navasa, M.; Mertens, B.J.A.; Rodriguez-Tajes, S.; Vree, M. de; Metselaar, H.J.; Chiang, F.W.T.; Verspaget, H.W.; Hoek, B. van; Bosch, J. & Coenraad, M.J. (2018), Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates, Clinical Transplantation 32(11).
- Goet, J.C.; Hansen, B.E.; Tieleman, M.; Hoek, B. van; Berg, A.P. van den; Polak, W.G.; Dubbeld, J.; Porte, R.J.; Konijn-Janssen, C.; Man, R.A. de; Metselaar, H.J. & Vries, A.C. de (2018), Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study, Transplant International 31(6): 590-599.
- Annema, C.; Drent, G.; Roodbol, P.F.; Stewart, R.E.; Metselaar, H.J.; Hoek, B. van; Porte, R.J. & Ranchor, A.V. (2018), Trajectories of Anxiety and Depression After Liver Transplantation as Related to Outcomes During 2-Year Follow-Up: A Prospective Cohort Study, Psychosomatic Medicine 80(2): 174-183.
- Blok, J.J.; Boer, J.D. de; Putter, H.; Rogiers, X.; Guba, M.O.; Strassburg, C.P.; Samuel, U.; Hoek, B. van; Hamming, J.F.; Braat, A.E. & Eurotransplant Liver Intestine (2018), The center effect in liver transplantation in the Eurotransplant region: a retrospective database analysis, Transplant International 31(6): 610-619.
- Blok, J.J.; Putter, H.; Metselaar, H.J.; Porte, R.J.; Gonella, F.; Jonge, J. de; Berg, A.P. van den; Zande, J. van der; Boer, J.D. de; Hoek, B. van & Braat, A.E. (2018), Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time, Transplantation Direct 4(9).
- Alberts, R.; Vries, E.M.G. de; Goode, E.C.; Jiang, X.J.; Sampaziotis, F.; Rombouts, K.; Bottcher, K.; Folseraas, T.; Weismuller, T.J.; Mason, A.L.; Wang, W.W.; Alexander, G.; Alvaro, D.; Bergquist, A.; Bjorkstrom, N.K.; Beuers, U.; Bjornsson, E.; Boberg, K.M.; Bowlus, C.L.; Bragazzi, M.C.; Carbone, M.; Chazouilleres, O.; Cheung, A.; Dalekos, G.; Eaton, J.; Eksteen, B.; Ellinghaus, D.; Farkkila, M.; Festen, E.A.M.; Floreani, A.; Franceschet, I.; Gotthardt, D.N.; Hirschfield, G.M.; Hoek, B. van; Holm, K.; Hohenester, S.; Hov, J.R.; Imhann, F.; Invernizzi, P.; Juran, B.D.; Lenzen, H.; Lieb, W.; Liu, J.Z.; Marschall, H.U.; Marzioni, M.; Melum, E.; Milkiewicz, P.; Muller, T.; Pares, A.; Rupp, C.; Rust, C.; Sandford, R.N.; Schramm, C.; Schreiber, S.; Schrumpf, E.; Silverberg, M.S.; Srivastava, B.; Sterneck, M.; Teufel, A.; Vallier, L.; Verheij, J.; Vila, A.V.; Vries, B. de; Zachou, K.; Chapman, R.W.; Manns, M.P.; Pinzani, M.; Rushbrook, S.M.; Lazaridis, K.N.; Franke, A.; Anderson, C.A.; Karlsen, T.H.; Ponsioen, C.Y.; Weersma, R.K.; PSC Study Grp & UK PSC Consortium (2018), Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis, Gut 67(8): 1517-1524.
- Pietersen, L.; Hoek, B. van & Braat, A.E. (2018), Use of thrombolytic therapy in DCD liver transplantation does not seem to improve outcome, American Journal of Transplantation 18(4): 1029-1029.
- Dulk, A.C. den; Shi, X.L.; Verhoeven, C.J.; Dubbeld, J.; Claas, F.H.J.; Wolterbeek, R.; Brand-Schaaf, S.H.; Verspaget, H.W.; Sarasqueta, A.F.; Laan, L.J.W. van der; Metselaar, H.J.; Hoek, B. van; Kwekkeboom, J. & Roelen, D.L. (2018), Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation, Clinical Transplantation 32(2).
- Annema, C.; Roodbol, P.F.; Heuvel, E.R. van den; Metselaar, H.J.; Hoek, B. van; Porte, R.J. & Ranchor, A.V. (2017), Trajectories of anxiety and depression in liver transplant candidates during the waiting-list period, British Journal of Health Psychology 22(3): 481-501.
- Meeteren, M.J.W. van; Hayee, B.; Inderson, A.; Meulen, A.E. van der; Altwegg, R.; Hoek, B. van; Pageaux, G.P.; Stijnen, T.; Stein, D. & Maljaars, P.W.J. (2017), Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis, Journal of Crohn's and Colitis 11(9): 1146-1151.
- Ruijter, B.N.; Wijngaarden, A.K.S. van; Hoek, B. van; Mensen, M.; Soolingen, D. van & Arend, S.M. (2017), Donor-derived tuberculosis via orthotopic liver transplantation, Netherlands Journal of Medicine 75(9): 415-417.
- Bolier, R.; Vries, E.S. de; Pares, A.; Helder, J.; Kemper, E.M.; Zwinderman, K.; Elferink, R.P.O.; Beuers, U. & Netherlands Assoc Study Live (2017), Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial, Trials 18.
- Annema, C.; Drent, G.; Roodbol, P.F.; Metselaar, H.J.; Hoek, B. van; Porte, R.J.; Schroevers, M.J. & Ranchor, A.V. (2017), A prospective cohort study on posttraumatic stress disorder in liver transplantation recipients before and after transplantation: Prevalence, symptom occurrence, and intrusive memories, Journal of Psychosomatic Research 95: 88-93.
- Liberal, R.; Boer, Y.S. de; Andrade, R.J.; Bouma, G.; Dalekos, G.N.; Floreani, A.; Gleeson, D.; Hirschfield, G.M.; Invernizzi, P.; Lenzi, M.; Lohse, A.W.; Macedo, G.; Milkiewicz, P.; Terziroli, B.; Hoek, B. van; Vierling, J.M.; Heneghan, M.A. & Int Autoimmune Hepatitis Grp IAIH (2017), Expert clinical management of autoimmune hepatitis in the real world, Alimentary Pharmacology and Therapeutics 45(5): 723-732.
- Kerbert, A.J.C.; Verspaget, H.W.; Navarro, A.A.; Jalan, R.; Sola, E.; Benten, D.; Durand, F.; Gines, P.; Reijden, J.J. van der; Hoek, B. van; Coenraad, M.J. & EASL-CLIF Consortium (2017), Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival, Critical Care 21.
- Barendregt, J.; Jong, M. de; Haans, J.J.; Hoek, B. van; Hardwick, J.; Veenendaal, R.; Meulen, A. van der; Srivastava, N.; Stuyt, R. & Maljaars, J. (2017), Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn's disease, International Journal of Colorectal Disease 32(4): 459-467.
- Kerbert, A.J.C.; Schaapman, J.J.; Reijden, J.J. van der; Navarro, A.A.; McCormick, A.; Hoek, B. van; Arroyo, V.; Gines, P.; Jalan, R.; Vargas, V.; Stauber, R.; Verspaget, H.W.; Coenraad, M.J. & CANONIC Study Investigators EASL-C (2017), Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis, European Journal of Gastroenterology and Hepatology 29(5): 535-538.
- Kerbert, A.J.C.; Chiang, F.W.T.; Werf, M. van der; Stijnen, T.; Slingerland, H.; Verspaget, H.W.; Hoek, B. van & Coenraad, M.J. (2017), Hemodynamic response to primary prophylactic therapy with nonselective beta-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis, European Journal of Gastroenterology and Hepatology 29(4): 380-387.
- Manns, M.; Samuel, D.; Gane, E.J.; Mutimer, D.; McCaughan, G.; Buti, M.; Prieto, M.; Calleja, J.L.; Peck-Radosavljevic, M.; Mullhaupt, B.; Agarwal, K.; Angus, P.; Yoshida, E.M.; Colombo, M.; Rizzetto, M.; Dvory-Sobol, H.; Denning, J.; Arterburn, S.; Pang, P.S.; Brainard, D.; McHutchison, J.G.; Dufour, J.F.; Vlierberghe, H. van; Hoek, B. van; Forns, X. & SOLAR-2 Investigators (2016), Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial, Lancet Infectious Diseases 16(6): 685-697.
- Sola, E.; Kerbert, A.J.C.; Verspaget, H.W.; Moreira, R.; Pose, E.; Ruiz, P.; Cela, R.; Morales-Ruiz, M.; Lopez, E.; Graupera, I.; Sole, C.; Huelin, P.; Navarro, A.A.; Ariza, X.; Jalan, R.; Fabrellas, N.; Benten, D.; Prada, G. de; Durand, F.; Jimenez, W.; Reijden, J.J. van der; Fernandez, J.; Hoek, B. van; Coenraad, M.J. & Gines, P. (2016), Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis, Journal of Hepatology 65(5): 914-920.
- Blok, J.J.; Detry, O.; Putter, H.; Rogiers, X.; Porte, R.J.; Hoek, B. van; Pirenne, J.; Metselaar, H.J.; Lerut, J.P.; Ysebaert, D.K.; Lucidi, V.; Troisi, R.I.; Samuel, U.; Dulk, A.C. den; Ringers, J.; Braat, A.E. & Eurotransplant Liver Intestine (2016), Longterm results of liver transplantation from donation after circulatory death.
- Moes, D.J.A.R.; Bent, S.A.S. van der; Swen, J.J.; Straaten, T. van der; Inderson, A.; Olofsen, E.; Verspaget, H.W.; Guchelaar, H.J.; Hartigh, J. den & Hoek, B. van (2016), Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients, European Journal of Clinical Pharmacology 72(2): 163-174.
- Ringers, J.; Bloemenkamp, K.W.M.; Francisco, N.; Blok, J.J.; Arbous, M.S. & Hoek, B. van (2016), Auxiliary or orthotopic liver transplantation foracute fatty liver of pregnancy: case series and review of the literature, BJOG: An International Journal of Obstetrics and Gynaecology 123(8): 1394-1398.
- Smolders, E.J.; Kanter, C.T.M.M. de; Hoek, B. van; Arends, J.E.; Drenth, J.P.H. & Burger, D.M. (2016), Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment.
- Moes, D.J.A.R.; Swen, J.J.; Bent, S.A.S. van der; Straaten, T. van der; Inderson, A.; Olofsen, E.; Verspaget, H.W.; Guchelaar, H.J.; Hartigh, J. den & Hoek, B. van (2016), Response: Limited sampling strategies for once daily tacrolimus exposure monitoring, European Journal of Clinical Pharmacology 72(6): 775-776.
- Kerbert, A.J.C.; Weil, D.; Verspaget, H.W.; Moreno, J.P.; Hoek, B. van; Cervoni, J.P.; Martino, V. di; Coenraad, M.J. & Thevenot, T. (2016), Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis, Liver International 36(4): 530-537.
- Geissler, E.K.; Schnitzbauer, A.A.; Zulke, C.; Lamby, P.E.; Proneth, A.; Duvoux, C.; Burra, P.; Jauch, K.W.; Rentsch, M.; Ganten, T.M.; Schmidt, J.; Settmacher, U.; Heise, M.; Rossi, G.; Cillo, U.; Kneteman, N.; Adam, R.; Hoek, B. van; Bachellier, P.; Wolf, P.; Rostaing, L.; Bechstein, W.O.; Rizell, M.; Powell, J.; Hidalgo, E.; Gugenheim, J.; Wolters, H.; Brockmann, J.; Roy, A.; Mutzbauer, I.; Schlitt, A.; Beckebaum, S.; Graeb, C.; Nadalin, S.; Valente, U.; Turrion, V.S.; Jamieson, N.; Scholz, T.; Colledan, M.; Fandrich, F.; Becker, T.; Soderdahl, G.; Chazouilleres, O.; Makisalo, H.; Pageaux, G.P.; Steininger, R.; Soliman, T.; Jong, K.P. de; Pirenne, J.; Margreiter, R.; Pratschke, J.; Pinna, A.D.; Hauss, J.; Schreiber, S.; Strasser, S.; Klempnauer, J.; Troisi, R.I.; Bhoori, S.; Lerut, J.; Bilbao, I.; Klein, C.G.; Konigsrainer, A.; Mirza, D.F.; Otto, G.; Mazzaferro, V.; Neuhaus, P. & Schlitt, H.J. (2016), Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial, Transplantation 100(1): 116-125.
- Huisman, E.J.; Meer, S. van; Hoek, B. van; Soest, H. van; Nieuwkerk, K.M.J. van; Arends, J.E.; Siersema, P.D. & Erpecum, K.J. van (2016), Effects of preventive versus "on-demand'' nutritional support on paid labour productivity, physical exercise and performance status during PEG-interferon-containing treatment for hepatitis C, Clinics and Research in Hepatology and Gastroenterology 40(2): 221-229.
- Holster, I.L.; Tjwa, E.T.T.L.; Moelker, A.; Wils, A.; Hansen, B.E.; Vermeijden, J.R.; Scholten, P.; Hoek, B. van; Nicolai, J.J.; Kuipers, E.J.; Pattynama, P.M.T. & Buuren, H.R. van (2016), Covered Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Therapy plus beta-blocker for Prevention of Variceal Rebleeding, Hepatology 63(2): 581-589.
- Pietersen, L.C.; Dulk, A.C. den; Braat, A.E.; Putter, H.; Korkmaz, K.S.; Baranski, A.G.; Schaapherder, A.F.M.; Dubbeld, J.; Hoek, B. van & Ringers, J. (2016), Flushing the liver with urokinase before transplantation does not prevent nonanastomotic biliary strictures, Liver Transplantation 22(4): 420-426.
- Berden, F.A.C.; Knegt, R.J. de; Blokzijl, H.; Kuiken, S.D.; Erpecum, K.J.L. van; Willemse, S.B.; Hollander, J. den; Vonderen, M.G.A. van; Friederich, P.; Hoek, B. van; Nieuwkerk, C.M.J. van; Drenth, J.P.H. & Kievit, W. (2016), Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study, PLoS ONE 11(9).
- Ottevanger, J.W.; Rijswijk, C.S.P. van; Hoek, B. van & Burgmans, M.C. (2015), Gastric Variceal Hemorrhage in a Noncirrhotic Patient Treated with Balloon-Occluded Retrograde Transvenous Obliteration, CardioVascular and Interventional Radiology 38(4): 1060-1063.
- Dubbeld, J.; Hoek, B. van; Ringers, J.; Metselaar, H.; Kazemier, G.; Berg, A. van den & Porte, R.J. (2015), Biliary Complications After Liver Transplantation From Donation After Cardiac Death Donors: An Analysis of Risk Factors and Long-term Outcome From a Single Center, Annals of Surgery 261(3): E64-E64.
- Westerkamp, A.C.; Korkmaz, K.S.; Bottema, J.T.; Ringers, J.; Polak, W.G.; Berg, A. van den; Hoek, B. van; Metselaar, H.J. & Porte, R.J. (2015), Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study, Clinical Transplantation 29(7): 636-643.
- Blok, J.J.; Putter, H.; Rogiers, X.; Hoek, B. van; Samuel, U.; Ringers, J.; Braat, A.E. & Eurotransplant Liver Intestine Adv (2015), Combined Effect of Donor and Recipient Risk on Outcome After Liver Transplantation: Research of the Eurotransplant Database, Liver Transplantation 21(12): 1486-1493.
- Dulk, A.C. den; Korkmaz, K.S.; Rooij, B.J.F. de; Sutton, M.E.; Braat, A.E.; Inderson, A.; Dubbeld, J.; Verspaget, H.W.; Porte, R.J. & Hoek, B. van (2015), High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death, Transplant International 28(4): 492-501.
- Kerbert, A.J.C.; Verbeke, L.; Chiang, F.W.T.; Laleman, W.; Reijden, J.J. van der; Duijn, W. van; Nevens, F.; Wolterbeek, R.; Hoek, B. van; Verspaget, H.W. & Coenraad, M.J. (2015), Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis, PLoS ONE 10(9).
- Gerven, N.M.F. van; Boer, Y.S. de; Zwiers, A.; Verwer, B.J.; Drenth, J.P.H.; Hoek, B. van; Erpecum, K.J. van; Beuers, U.; Buuren, H.R. van; Ouden, J.W. den; Verdonk, R.C.; Koek, G.H.; Brouwer, J.T.; Guichelaar, M.J.; Vrolijk, J.M.; Coenraad, M.J.; Kraal, G.; Mulder, C.J.J.; Nieuwkerk, C.M.J. van; Bloemena, E.; Verspaget, H.W.; Kumar, V.; Zhernakova, A.; Wijmenga, C.; Franke, L.; Bouma, G. & Dutch Autoimmune Hepatitis Study G (2015), HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1, Genes and Immunity 16(4): 247-252.
- Roth, D.; Nelson, D.R.; Bruchfeld, A.; Liapakis, A.; Silva, M.; Monsour, H.; Martin, P.; Pol, S.; Londono, M.C.; Hassanein, T.; Zamor, P.J.; Zuckerman, E.; Wan, S.; Jackson, B.; Nguyen, B.Y.; Robertson, M.; Barr, E.; Wahl, J. & Greaves, W. (2015), Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study, Lancet 386(10003): 1537-1545.
- Gerven, N.M.F. van; Verwer, B.J.; Witte, B.I.; Erpecum, K.J. van; Buuren, H.R. van; Maijers, I.; Visscher, A.P.; Verschuren, E.C.; Hoek, B. van; Coenraad, M.J.; Beuers, U.H.W.; Man, R.A. de; Drenth, J.P.H.; Ouden, J.W. den; Verdonk, R.C.; Koek, G.H.; Brouwer, J.T.; Guichelaar, M.M.J.; Vrolijk, J.M.; Mulder, C.J.J.; Nieuwkerk, C.M.J. van; Bouma, G. & Dutch Autoimmune Hepatitis STUDY (2014), Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands, Scandinavian Journal of Gastroenterology 49(10): 1245-1254.
- Berden, F.A.C.; Kievit, W.; Baak, L.C.; Bakker, C.M.; Beuers, U.; Boucher, C.A.B.; Brouwer, J.T.; Burger, D.M.; Erpecum, K.J.L. van; Hoek, B. van; Hoepelman, A.I.M.; Honkoop, P.; Kerbert-Dreteler, M.J.; Knegt, R.J. de; Koek, G.H.; Nieuwkerk, C.M.J. van; Soest, H. van; Tan, A.C.I.T.L.; Vrolijk, J.M. & Drenth, J.P.H. (2014), Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era, Netherlands Journal of Medicine 72(8): 388-400.
- Zeuzem, S.; Dusheiko, G.M.; Salupere, R.; Mangia, A.; Flisiak, R.; Hyland, R.H.; Illeperuma, A.; Svarovskaia, E.; Brainard, D.M.; Symonds, W.T.; Subramanian, M.; McHutchison, J.G.; Weiland, O.; Reesink, H.W.; Ferenci, P.; Hezode, C.; Esteban, R. & VALENCE Investigators (2014), Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3, New England Journal of Medicine 370(21): 1993-2001.
- Krol, C.G.; Dekkers, O.M.; Kroon, H.M.; Rabelink, T.J.; Hoek, B. van & Hamdy, N.A.T. (2014), No Association Between BMD and Prevalent Vertebral Fractures in Liver Transplant Recipients at Time of Screening Before Transplantation, Journal of Clinical Endocrinology and Metabolism 99(10): 3677-3685.
- Krol, C.G.; Dekkers, O.M.; Kroon, H.M.; Rabelink, T.J.; Hoek, B. van & Hamdy, N.A.T. (2014), Longitudinal Changes in BMD and Fracture Risk in Orthotopic Liver Transplant Recipients Not Using Bone-Modifying Treatment, Journal of Bone and Mineral Research 29(8): 1763-1769.
- Korkmaz, K.S.; Rooij, B.J.F. de; Hoek, B. van; Janse, M.; Coenraad, M.J.; Reijden, J.J. van der; Weersma, R.K.; Porte, R.J.; Voorneveld, P.W.; Baranski, A.G. & Verspaget, H.W. (2014), MMP-2 is a disease-modifying gene in primary sclerosing cholangitis, Liver International 34(2): 274-280.
- Langers, P.; Press, R.R.; Inderson, A.; Cremers, S.C.L.M.; Hartigh, J. den; Baranski, A.G. & Hoek, B. van (2014), Limited Sampling Model for Advanced Mycophenolic Acid Therapeutic Drug Monitoring After Liver Transplantation, Therapeutic Drug Monitoring 36(2): 141-147.
- Boer, Y.S. de; Gerven, N.M.F. van; Zwiers, A.; Verwer, B.J.; Hoek, B. van; Erpecum, K.J. van; Beuers, U.; Buuren, H.R. van; Drenth, J.P.H.; Ouden, J.W. den; Verdonk, R.C.; Koek, G.H.; Brouwer, J.T.; Guichelaar, M.M.J.; Vrolijk, J.M.; Kraal, G.; Mulder, C.J.J.; Nieuwkerk, C.M.J. van; Fischer, J.; Berg, T.; Stickel, F.; Sarrazin, C.; Schramm, C.; Lohse, A.W.; Weiler-Normann, C.; Lerch, M.M.; Nauck, M.; Volzke, H.; Homuth, G.; Bloemena, E.; Verspaget, H.W.; Kumar, V.; Zhernakova, A.; Wijmenga, C.; Franke, L.; Bouma, G.; Dutch Autoimmune Hepatitis Study; LifeLines Cohort Study & Study Hlth Pomerania (2014), Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1, Gastroenterology 147(2): 443-+.
- Boer, Y.S. de, Baven-Pronk, Hoek, B. van, A.M.C., Nieuwkerk & C.M.J. van (2013), Auto-immuunhepatatis.
- Janse, M.; Rooij, B.J.F. de; Hoek, B. van; Berg, A.P. van den; Porte, R.J.; Blokzijl, H.; Coenraad, M.J.; Hepkema, B.G.; Schaapherder, A.F.; Ringers, J.; Weersma, R.K. & Verspaget, H.W. (2013), Recipient's Genetic R702W NOD2 Variant Is Associated with an Increased Risk of Bacterial Infections after Orthotopic Liver Transplantation, PLoS ONE 8(8).
- Wesdorp, D.J.W.; Knoester, M.; Braat, A.E.; Coenraad, M.J.; Vossen, A.C.T.M.; Claas, E.C.J. & Hoek, B. (2013), Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective, Journal of Clinical Virology 58(1): 67-73.
- Hilst, C.S. van der; IJtsma, A.J.C.; Bottema, J.T.; Hoek, B. van; Dubbeld, J.; Metselaar, H.J.; Kazemier, G.; Berg, A.P. van den; Porte, R.J. & Slooff, M.J.H. (2013), The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study.
- Gerven, N.M.F. van; Boer, Y.S. de; Zwiers, A.; Hoek, B. van; Erpecum, K.J. van; Beuers, U.; Buuren, H.R. van; Drenth, J.P.H.; Ouden, J.W. den; Verdonk, R.C.; Koek, G.H.; Brouwer, J.T.; Guichelaar, M.M.J.; Vrolijk, J.M.; Kraal, G.; Mulder, C.J.J.; Nieuwkerk, C.M.J. van; Bouma, G. & Dutch Autoimmune Hepatitis Study G (2013), Cytotoxic T Lymphocyte Antigen-4+49A/G polymorphism does not affect susceptibility to autoimmune hepatitis, Liver International 33(7): 1039-1043.
- Korkmaz, K.S.; Hove, W.R. ten; Rooij, B.J.F. de; Hoek, B. van; Reijden, J.J. van der; Coenraad, M.J.; Dubbeld, J. & Verspaget, H.W. (2013), Acute Cellular Rejection Is Associated With Matrix Metalloproteinase-2 Genotype Chimerism After Orthotopic Liver Transplantation, Transplantation Proceedings 45(2): 558-563.
- Gerven, N.M.F. van; Verwer, B.J.; Witte, B.I.; Hoek, B. van; Coenraad, M.J.; Erpecum, K.J. van; Beuers, U.; Buuren, H.R. van; Man, R.A. de; Drenth, J.P.H.; Ouden, J.W. den; Verdonk, R.C.; Koek, G.H.; Brouwer, J.T.; Guichelaar, M.M.J.; Mulder, C.J.J.; Nieuwkerk, K.M.J. van & Bouma, G. (2013), Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission, Journal of Hepatology 58(1): 141-147.
- Boonstra, K.; Weersma, R.K.; Erpecum, K.J. van; Rauws, E.A.; Spanier, B.W.M.; Poen, A.C.; Nieuwkerk, K.M. van; Drenth, J.P.; Witteman, B.J.; Tuynman, H.A.; Naber, A.H.; Kingma, P.J.; Buuren, H.R. van; Hoek, B. van; Vleggaar, F.P.; Geloven, N. van; Beuers, U.; Ponsioen, C.Y. & EpiPSCPBC Study Grp (2013), Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis, Hepatology 58(6): 2045-2055.
- Lamers, H.; Broekman, M.M.T.J.; Boucher, C.A.; Brouwer, J.T.; Burger, D.M.; Hoek, B. van; Hoepelman, A.I.M.; Knegt, R.J. de; Reesink, H.W.; Drenth, J.P.H.; Netherlands Assoc; Netherlands Assoc Internal Med & Dutch Assoc Study Liver Dis (2013), Treatment of hepatitis C monoinfection in adults - Dutch national guidelines, Netherlands Journal of Medicine 71(7): 377-385.
- Huisman, E.J.; Hoek, B. van; Soest, H. van; Nieuwkerk, K.M. van; Arends, J.E.; Siersema, P.D. & Erpecum, K.J. van (2012), Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: A randomized controlled trial, Journal of Hepatology 57(5): 1069-1075.
- Seinstra, B.A.; Defreyne, L.; Lambert, B.; Lam, M.G.E.H.; Verkooijen, H.M.; Erpecum, K.J. van; Hoek, B. van; Erkel, A.R. van; Coenraad, M.J.; Younis, I. al; Vlierberghe, H. van & Bosch, M.A.A.J. van den (2012), Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial, Trials 13: -.
- Paassen, J. van; Bauer, M.P.; Arbous, M.S.; Visser, L.G.; Schmidt-Chanasit, J.; Schilling, S.; Olschlager, S.; Rieger, T.; Emmerich, P.; Schmetz, C.; Berkmortel, F. van de; Hoek, B. van; Burgel, N.D. van; Osterhaus, A.D.; Vossen, A.C.T.M.; Gunther, S. & Dissel, J.T. van (2012), Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever.
- Mergental, H.; Adam, R.; Ericzon, B.G.; Kalicinski, P.; Muhlbacher, F.; Hockerstedt, K.; Klempnauer, J.L.; Friman, S.; Broelsch, C.E.; Mantion, G.; Fernandez-Sellez, C.; Hoek, B. van; Fangmann, J.; Pirenne, J.; Muiesan, P.; Konigsrainer, A.; Mirza, D.F.; Lerut, J.; Detry, O.; Treut, Y.P. le; Mazzaferro, V.; Lohe, F.; Berenguer, M.; Clavien, P.A.; Rogiers, X.; Belghiti, J.; Kobori, L.; Burra, P.; Wolf, P.; Schareck, W.; Pisarski, P.; Foss, A.; Filipponi, F.; Krawczyk, M.; Wolff, M.; Langrehr, J.M.; Rolles, K.; Jamieson, N.; Hop, W.C.J. & Porte, R.J. (2012), Liver transplantation for unresectable hepatocellular carcinoma in normal livers, Journal of Hepatology 57(2): 297-305.
- Langers & P (2012), Monitoring immunosuppression after liver transplantation; development of individualized Bayesian limited sampling monitoring.
- Hoek, B. van; Rooij, B.J. de & Verspaget, H.W. (2012), Risk factors for infection after liver transplantation, BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY 26(1): 61-72.
- Vlerken, L.G. van; Huisman, E.J.; Hoek, B. van; Renooij, W.; Rooij, F.W.M. de; Siersema, P.D. & Erpecum, K.J. van (2012), Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability, European Journal of Clinical Investigation 42(7): 760-767.
- Abdelmalek, M.F.; Humar, A.; Stickel, F.; Andreone, P.; Pascher, A.; Barroso, E.; Neff, G.W.; Ranjan, D.; Toselli, L.T.; Gane, E.J.; Scarola, J.; Alberts, R.G.; Maller, E.S.; , C.M. lo & Sirolimus Liver Conversion Trial S (2012), Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial, American Journal of Transplantation 12(3): 694-705.
- Buster, E.H.C.J.; Baak, B.C.; Bakker, C.M.; Beuers, U.H.W.; Brouwer, J.T.; Drenth, J.P.H.; Erpecum, K.J. van; Hoek, B. van; Honkoop, P.; Kerbert-Dreteler, M.J.; Koek, G.H.; Nieuwkerk, K.M.J. van; Soest, H. van; Spek, B.W. van der; Tan, A.C.I.T.L.; Vrolijk, J.M. & Janssen, H.L.A. (2012), The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
- Keimpema, L. van; Koning, D.B. de; Hoek, B. van; Berg, A.P. van den; Oijen, M.G.H. van; Man, R.A. de; Nevens, F. & Drenth, J.P.H. (2011), Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases, Liver International 31(1): 92-98.
- Oprea-Lager, D.E.; Sorgdrager, B.J.; Jukema, J.W.; Scherptong, R.W.C.; Ringers, J.; Coenraad, M.J.; Hoek, B. van & Stokkel, M.P.M. (2011), Clinical Value of Myocardial Perfusion Scintigraphy as a Screening Tool in Liver Transplant Candidates, Liver Transplantation 17(3): 261-269.
- Dubbeld, J.; Hoek, B. van & Ringers, J. (2011), Use of a liver from donor after cardiac death: is it appropriate for the sick or the stable?, Current Opinion in Organ Transplantation 16(2): 239-242.
- Rooij, B.J.F. de; Beek, M.T. van der; Hoek, B. van; Vossen, A.C.T.M.; Hove, W.R. ten; Roos, A.; Schaapherder, A.F.; Porte, R.J.; Reijden, J.J. van der; Coenraad, M.J.; Hommes, D.W. & Verspaget, H.W. (2011), Mannose-binding lectin and Ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation, Journal of Hepatology 55(4): 800-807.
- Hove, W.R. ten; Korkmaz, K.S.; Dries, S.O. den; Rooij, B.J.F. de; Hoek, B. van; Porte, R.J.; Reijden, J.J. van der; Coenraad, M.J.; Dubbeld, J.; Hommes, D.W. & Verspaget, H.W. (2011), Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation.
- Veek, P.P.J. van der; Cappel, W.H.D.T.N.; Langers, A.J. & Hoek, B. van (2011), Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy?, Gastroenterology Research and Practice.
- Zeuzem, S.; Andreone, P.; Pol, S.; Lawitz, E.; Diago, M.; Roberts, S.; Focaccia, R.; Younossi, Z.; Foster, G.R.; Horban, A.; Ferenci, P.; Nevens, F.; Mullhaupt, B.; Pockros, P.; Terg, R.; Shouval, D.; Hoek, B. van; Weiland, O.; Heeswijk, R. van; Meyer, S. de; Luo, D.; Boogaerts, G.; Polo, R.; Picchio, G.; Beumont, M. & REALIZE Study Team (2011), Telaprevir for Retreatment of HCV Infection, New England Journal of Medicine 364(25): 2417-2428.
- Baven-Pronk, A.M.C.; Coenraad, M.J.; Buuren, H.R. van; Man, R.A. de; Erpecum, K.J. van; Lamers, M.M.H.; Drenth, J.P.H.; Berg, A.P. van den; Beuers, U.H.; Ouden, J. den; Koek, G.H.; Nieuwkerk, C.M.J. van; Bouma, G.; Brouwer, J.T. & Hoek, B. van (2011), Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes: authors' reply, Alimentary Pharmacology and Therapeutics 34(6): 684-685.
- Baven-Pronk, A.M.C.; Coenraad, M.J.; Buuren, H.R. van; Man, R.A. de; Erpecum, K.J. van; Lamers, M.M.H.; Drenth, J.P.H.; Berg, A.P. van den; Beuers, U.H.; Ouden, J. den; Koek, G.H.; Nieuwkerk, C.M.J. van; Bouma, G.; Brouwer, J.T. & Hoek, B. van (2011), The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes, Alimentary Pharmacology and Therapeutics 34(3): 335-343.
- Huisman, E.J.; Trip, E.J.; Siersema, P.D.; Hoek, B. van & Erpecum, K.J. van (2011), Protein energy malnutrition predicts complications in liver cirrhosis, European Journal of Gastroenterology and Hepatology 23(11): 982-989.
- Stuyt, R.J.L.; Willems, S.M.; Wagtmans, M.J. & Hoek, B. van (2011), Chewing khat and chronic liver disease, Liver International 31(3): 435-436.
- McHutchison, J.G.; Manns, M.P.; Muir, A.J.; Terrault, N.A.; Jacobson, I.M.; Afdhal, N.H.; Heathcote, E.J.; Zeuzem, S.; Reesink, H.W.; Garg, J.; Bsharat, M.; George, S.; Kauffman, R.S.; Adda, N.; Bisceglie, A.M. di & PROVE3 Study Team (2010), Telaprevir for Previously Treated Chronic HCV Infection., New England Journal of Medicine 362(14): 1292-1303.
- Kuiper, E.M.M.; Hansen, B.E.; Adang, R.P.R.; Nieuwkerk, C.M.J. van; Timmer, R.; Drenth, J.P.H.; Spoelstra, P.; Brouwer, H.T.; Kuyvenhoven, J.P.H.; Buuren, H.R. van & Dutch PBC Study Grp (2010), Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid, European Journal of Gastroenterology and Hepatology 22(12): 1495-1502.
- Soest, H. van; Schaar, P.J. van der; Koek, G.H.; Vries, R.A. de; Ooteghem, N.A. van; Hoek, B. van; Drenth, J.P.H.; Vrolijk, J.M.; Lieverse, R.J.; Houben, P.; Veer, A.V.; Siersema, P.D.; Schipper, M.E.I.; Erpecum, K.J. van & Boland, G.J. (2010), No beneficial effects of amantadine in treatment of chronic hepatitis C patients, Digestive and Liver Disease 42(7): 496-502.
- Kuiper, E.M.M.; Hansen, B.E.; Metselaar, H.J.; Man, R.A. de; Haagsma, E.B.; Hoek, B. van & Buuren, H.R. van (2010), Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008, BMC Gastroenterology 10.
- Rooij, B.J.F. de; Hoek, B. van; Hove, W.R. ten; Roos, A.; Bouwman, L.H.; Schaapherder, A.F.; Porte, R.J.; Daha, M.R.; Reijden, J.J. van der; Coenraad, M.J.; Ringers, J.; Baranski, A.G.; Hepkema, B.G.; Hommes, D.W. & Verspaget, H.W. (2010), Lectin Complement Pathway Gene Profile of Donor and Recipient Determine the Risk of Bacterial Infections After Orthotopic Liver Transplantation, Hepatology 52(3): 1100-1110.
- Dubbeld, J.; Hoekstra, H.; Farid, W.; Ringers, J.; Porte, R.J.; Metselaar, H.J.; Baranski, A.G.; Kazemier, G.; Berg, A.P. van den & Hoek, B. van (2010), Similar liver transplantation survival with selected cardiac death donors and brain death donors (Br J Surg 2010; 97: 744-753) Reply, British Journal of Surgery 97(8): 1310-1311.
- Schnitzbauer, A.A.; Zuelke, C.; Graeb, C.; Rochon, J.; Bilbao, I.; Burra, P.; Jong, K.P. de; Duvoux, C.; Kneteman, N.M.; Adam, R.; Bechstein, W.O.; Becker, T.; Beckebaum, S.; Chazouilleres, O.; Cillo, U.; Colledan, M.; Fandrich, F.; Gugenheim, J.; Hauss, J.P.; Heise, M.; Hidalgo, E.; Jamieson, N.; Konigsrainer, A.; Lamby, P.E.; Lerut, J.P.; Makisalo, H.; Margreiter, R.; Mazzaferro, V.; Mutzbauer, I.; Otto, G.; Pageaux, G.P.; Pinna, A.D.; Pirenne, J.; Rizell, M.; Rossi, G.; Rostaing, L.; Roy, A.; Turrion, V.S.; Schmidt, J.; Troisi, R.I.; Hoek, B. van; Valente, U.; Wolf, P.; Wolters, H.; Mirza, D.F.; Scholz, T.; Steininger, R.; Soderdahl, G.; Strasser, S.I.; Jauch, K.W.; Neuhaus, P.; Schlitt, H.J. & Geissler, E.K. (2010), A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma, BMC Cancer 10.
- Dubbeld, J.; Hoekstra, H.; Farid, W.; Ringers, J.; Porte, R.J.; Metselaar, H.J.; Baranski, A.G.; Kazemier, G.; Bere, A.P. van den & Hoek, B. van (2010), Similar liver transplantation survival with selected cardiac death donors and brain death donors, British Journal of Surgery 97(5): 744-753.
- Tervaert JWC, Van Hoek B & Koek G (2009), Antineutrophil Cytoplasmic Antibodies in Small-Duct Primary Sclerosing Cholangitis, Gastroenterology 136(1): 364-364.
- Mazzoferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME & Grazi GL (2009), Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis, Lancet Oncology 10(1): 35-43.
- Kuiper Edith M. M., Hansen Bettina E., de Vries Richard A., den Ouden-Muller Jannie W., Van Ditzhuijsen Theo J. M., Haagsma Els B., Houben Martin H. M. G., Witteman Ben J. M., van Erpecum Karel J. & van Buuren Henk R. (2009), Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid, Gastroenterology 136(4): 1281-1287.
- Wils A, van der Linden E, van Hoek B & Pattynama PMT (2009), Transjugular Intrahepatic Portosystemic Shunt in Patients With Chronic Portal Vein Occlusion and Cavernous Transformation, Journal of Clinical Gastroenterology 43(10): 982-984.
- Dahlke MH, Hoogduijn M, Eggenhofer E, Popp FC, Renner P, Slowik P, Rosenauer A, Piso P, Geissler EK, Lange C, Chabannes D, Mazzanti B, Bigenzahn S, Bertolino P, Kunter U, Introna M, Rambaldi A, Capelli C, Perico N & Casiraghi F (2009), Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group, Transplantation 88(5): 614-619.
- Langers P, Press RR, den Hartigh J, Cremers SCLM, Baranski AG, Lamers CBHW, Hommes DW & van Hoek B (2008), Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration, Therapeutic Drug Monitoring 30(4).
- Cappel WHDTN, Dubbeld J, Willems SM, Ringers J & van Hoek B (2008), Liver transplantation in a patient with encapsulating peritoneal sclerosis, Netherlands Journal of Medicine 66(7).
- Vaessen N, Verweij JJ, Spijkerman IJB, van Hoek B & van Lieshout L (2007), Fatal disseminated toxoplasmosis after liver transplantation: improved and early diagnosis by PCR, Netherlands Journal of Medicine 65(6).
- Langers P, Cremers SCLM, den Hartigh J, Rijnbeek EMT, Ringers J, Lamers CBHW, Hommes DW & van Hoek B (2007), Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practice, Alimentary Pharmacology and Therapeutics 26(10).
- Ringers J, Dubbeld J, Baranski AG, Coenraad M, Sarton E, Schaapherder AFM & van Hoek B (2007), Reuse of auxiliary liver grafts in second recipients with chronic liver disease, American Journal of Transplantation 7(11).
- Bergmann JF, Vrolijk JM, van der Schaar P, Vroom B, van Hoek B, Veer AV, de Vries RA, Verhey E, Hansen BE, Brouwer JT, Janssen HLA, Schalm SW & de Knegt RJ (2007), g-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders, Liver International 27(9).
- Kok KF, Wahab PJ, Houwen RHJ, Drenth JPH, de Man RA, van Hoek B, Meijer JWR, Willekens FLA & de Vries RA (2007), Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review, Netherlands Journal of Medicine 65(5).
- de Bruijne ELE, Murad SD, de Maat MPM, Tanck MWT, Haagsma EB, van Hoeks B, Rosendaal FR, Janssen HLA & Leebeek FWG (2007), Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAR) is associated with the risk of splanchnic vein thrombosis, Thrombosis and Haemostasis 97(2).
- ten Hove WR, Verspaget HW, Barge R, Lamers CB & van Hoek B (2007), Liver chimerism after allogeneic blood stem cell transplantation, Transplantation Proceedings 39(1).
- van Dam AP, Pronk M, van Hoek B & Claas ECJ (2006), Successful treatment of Legionella maceachernii pneumonia after diagnosis by polymerase chain reaction and culture, Clinical Infectious Diseases 42(7).
- Smink F, van Hoek B, Ringers J, van Altena R & Arend SM (2006), Risk factors of acute hepatic failure during antituberculosis treatment: two cases and literature review, Netherlands Journal of Medicine 64(10).
- Ringers J, Baranski AG, Dubbeld J, Sarton E, Veenendaal RA, Schaapherder AFM, van der Linden E, Terpstra OT & van Hoek B (2006), A novel technique for auxiliary partial liver transplantation with reno-portal anastomosis and avoidance of the hepatoduodenal ligament, American Journal of Transplantation 6(11).
- Roos A, Bouwman LH, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, van der Slik AR, Doxiadis II, Roep BO & Schaapherder AFM (2006), Mannose-binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation, Molecular Immunology 43(1-2).
- Langers P, Cremers SCLM, Hartigh J, Rijnbeek EMT, Ringers J, Lamers CBHW & Van Hoek B (2005), Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation, Alimentary Pharmacology and Therapeutics 21(5).
- Verspaget HW, Kuyvenhoven JP & van Hoek B (2005), Preanalytical conditions and circulating matrix metalloproteinases, Transplantation 79(6).
- Bouwman LH, Terpstra OT, Schaapherder AFM, Roos A, Berger SP, Daha MR, De Knijff P, Van Hoek B, Verspaget HW, Frolich M, Van der Slik AR, Doxiadis II & Roep BO (2005), Mannose-binding lectin and liver transplantation - Reply, Gastroenterology 129(5).
- Bouwman LH, Roos A, Terpstra OT, De Knijff P, Van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, Van Der Slik AR, Doxiadis II, Roep BO & Schaapherder AFM (2005), Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation, Gastroenterology 129(2).
- van Hoek B (2004), Non-alcoholic fatty liver disease: A brief review, Scandinavian Journal of Gastroenterology 39.
- Kuyvenhoven JP, Verspaget HW, Gao Q, Ringers J, Smit VTHBM, Lamers CBHW & Van Hoek B (2004), Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: Increased serum MMP-9 level in acute rejection, Transplantation 77(11).
- Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JAM, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR & Janssen HLA (2004), Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome, Hepatology 39(2).
- Langers P, Cremers SCLM, den Hartigh J, Veenendaal RA, ten Hove WR, Ringers J, Lamers CBHW & van Hoek B (2004), Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients, Liver Transplantation 10(2).
- Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra O, Lamers CBHW, van Hoek B & Porte RJ (2004), Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation - The effect of aprotinin and the relation to ischemia/reperfusion injury, Thrombosis and Haemostasis 91(3).
- Schinkel J, de Jong MD, Bruning B, van Hoek B, Spaan WJM & Kroes ACM (2003), The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis, Antiviral Therapy 8(6).
- Veldt BJ, Brouwer JT, Adler M, Nevens F, Michielsen P, Delwaide J, Hansen BE & Schalm SW (2003), Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378], BMC Gastroenterology 3.
- Kuyvenhoven JP, Ringers J, Verspaget HW, Lamers CBHW & van Hoek B (2003), Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation, Transplantation Proceedings 35(8).
- ten Hove WR, van Hoek B, Bajema IM, Ringers J, van Krieken JHJM & Lagaaij EL (2003), Extensive chimerism in liver transplants: Vascular endothelium, bile duct epithelium, and hepatocytes, Liver Transplantation 9(6).
- Kuyvenhoven JP, van Hoek B, Blom E, van Duijn W, Hanemaaijer R, Verheijen JH, Lamers CBHW & Verspaget HW (2003), Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma, Thrombosis and Haemostasis 89(4).
- Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WCJ & Janssen HLA (2001), The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome, Journal of Hepatology 35(3).
- Schaar CG, van der Pijl JW, van Hoek B, de Fijter JW, Veenendaal RA, Kluin PM, van Krieken JHJ, Hekman A, Terpstra WE, Willemze R & Kluin-Nelemans HC (2001), Successful outcome with a "quintuple approach" of posttransplant lymphoproliferative disorder, Transplantation 71(1).
- Schinkel J, Kroes ACM, Wagtmans MJ, Lamers CBHW & van Hoek B (2001), Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays, Journal of Clinical Virology 22(1).
- Janssen HLA, Wijnhoud A, Haagsma EB, van Uum SHM, van Nieuwkerk CMJ, Adang RP, Chamuleau RAFM, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR & van Hoek B (2001), Extrahepatic portal vein thrombosis: aetiology and determinants of survival, Gut 49(5).
- Kuyvenhoven JP, Lamers CBHW & van Hoek B (2001), Practical management of hepatocellular carcinoma, Scandinavian Journal of Gastroenterology 36.
- de Moor RA, Schweizer JJ, van Hoek B, Wasser M, Vink R & Maaswinkel-Mooy PD (2000), Hepatocellular carcinoma in glycogen storage disease type IV.
- Janssen HLA, Meinardi JR, Vleggaar FP, van Uum SHM, Haagsma EB, van der Meer FJM, van Hattum J, Chamuleau RAFM, Adang RP, Vandenbroucke JP, van Hoek B & Rosendaal FR (2000), Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study, Blood 96(7).
- Veenendaal RA, Ringers J, Baranski A, van Hoek B & Lamers CBHW (2000), Clinical aspects of small-bowel transplantation, Scandinavian Journal of Gastroenterology 35.
- Advisory board
- Research- , education-, implementation grants
- Hoofdredacteurschappen nascholing online en abstractblad
- Hoofdredacteurschappen nascholing online en abstractblad
- Adviesraad
- Expertise rapporten rechtbanken